| Year |
Citation |
Score |
| 2019 |
van Dongen MJP, Kadam RU, Juraszek J, Lawson E, Brandenburg B, Schmitz F, Schepens WBG, Stoops B, van Diepen HA, Jongeneelen M, Tang C, Vermond J, van Eijgen-Obregoso Real A, Blokland S, Garg D, ... ... Goudsmit J, et al. A small-molecule fusion inhibitor of influenza virus is orally active in mice. Science (New York, N.Y.). 363. PMID 30846569 DOI: 10.1126/Science.Aar6221 |
0.329 |
|
| 2017 |
Sutton TC, Lamirande EW, Bock KW, Moore IN, Koudstaal W, Rehman M, Weverling GJ, Goudsmit J, Subbarao K. In vitro neutralization is not predictive of prophylactic efficacy of broadly neutralizing monoclonal antibodies CR6261 and CR9114 against lethal H2 influenza virus challenge in mice. Journal of Virology. PMID 29046448 DOI: 10.1128/Jvi.01603-17 |
0.316 |
|
| 2017 |
Pascual G, Wadia JS, Zhu X, Keogh E, Kükrer B, van Ameijde J, Inganäs H, Siregar B, Perdok G, Diefenbach O, Nahar T, Sprengers I, Koldijk MH, der Linden EC, Peferoen LA, ... ... Goudsmit J, et al. Immunological memory to hyperphosphorylated tau in asymptomatic individuals. Acta Neuropathologica. PMID 28341999 DOI: 10.1007/S00401-017-1705-Y |
0.322 |
|
| 2016 |
Cox F, Kwaks T, Brandenburg B, Koldijk MH, Klaren V, Smal B, Korse HJ, Geelen E, Tettero L, Zuijdgeest D, Stoop EJ, Saeland E, Vogels R, Friesen RH, Koudstaal W, ... Goudsmit J, et al. HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids. Frontiers in Immunology. 7: 399. PMID 27746785 DOI: 10.3389/Fimmu.2016.00399 |
0.311 |
|
| 2015 |
Impagliazzo A, Milder F, Kuipers H, Wagner MV, Zhu X, Hoffman RM, van Meersbergen R, Huizingh J, Wanningen P, Verspuij J, de Man M, Ding Z, Apetri A, Kükrer B, Sneekes-Vriese E, ... ... Goudsmit J, et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science (New York, N.Y.). 349: 1301-6. PMID 26303961 DOI: 10.1126/Science.Aac7263 |
0.302 |
|
| 2015 |
Roos A, Roozendaal R, Theeuwsen J, Riahi S, Vaneman J, Tolboom J, Dekking L, Koudstaal W, Goudsmit J, Radoševi? K. Protection against H5N1 by multiple immunizations with seasonal influenza vaccine in mice is correlated with H5 cross-reactive antibodies. Vaccine. 33: 1739-47. PMID 25659276 DOI: 10.1016/J.Vaccine.2015.01.070 |
0.303 |
|
| 2014 |
Otterstrom JJ, Brandenburg B, Koldijk MH, Juraszek J, Tang C, Mashaghi S, Kwaks T, Goudsmit J, Vogels R, Friesen RH, van Oijen AM. Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level. Proceedings of the National Academy of Sciences of the United States of America. 111: E5143-8. PMID 25404330 DOI: 10.1073/Pnas.1411755111 |
0.342 |
|
| 2014 |
Friesen RH, Lee PS, Stoop EJ, Hoffman RM, Ekiert DC, Bhabha G, Yu W, Juraszek J, Koudstaal W, Jongeneelen M, Korse HJ, Ophorst C, Brinkman-van der Linden EC, Throsby M, Kwakkenbos MJ, ... ... Goudsmit J, et al. A common solution to group 2 influenza virus neutralization. Proceedings of the National Academy of Sciences of the United States of America. 111: 445-50. PMID 24335589 DOI: 10.1073/Pnas.1319058110 |
0.317 |
|
| 2013 |
Brandenburg B, Koudstaal W, Goudsmit J, Klaren V, Tang C, Bujny MV, Korse HJ, Kwaks T, Otterstrom JJ, Juraszek J, van Oijen AM, Vogels R, Friesen RH. Mechanisms of hemagglutinin targeted influenza virus neutralization. Plos One. 8: e80034. PMID 24348996 DOI: 10.1371/Journal.Pone.0080034 |
0.377 |
|
| 2013 |
Baden LR, Walsh SR, Seaman MS, Tucker RP, Krause KH, Patel A, Johnson JA, Kleinjan J, Yanosick KE, Perry J, Zablowsky E, Abbink P, Peter L, Iampietro MJ, Cheung A, ... ... Goudsmit J, et al. First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). The Journal of Infectious Diseases. 207: 240-7. PMID 23125444 DOI: 10.1093/Infdis/Jis670 |
0.436 |
|
| 2013 |
Barouch DH, Liu J, Peter L, Abbink P, Iampietro MJ, Cheung A, Alter G, Chung A, Dugast AS, Frahm N, McElrath MJ, Wenschuh H, Reimer U, Seaman MS, Pau MG, ... ... Goudsmit J, et al. Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). The Journal of Infectious Diseases. 207: 248-56. PMID 23125443 DOI: 10.1093/Infdis/Jis671 |
0.425 |
|
| 2012 |
Zahn R, Gillisen G, Roos A, Koning M, van der Helm E, Spek D, Weijtens M, Grazia Pau M, Radoševi? K, Weverling GJ, Custers J, Vellinga J, Schuitemaker H, Goudsmit J, Rodríguez A. Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species. Plos One. 7: e44115. PMID 23236343 DOI: 10.1371/Journal.Pone.0044115 |
0.301 |
|
| 2012 |
Dreyfus C, Laursen NS, Kwaks T, Zuijdgeest D, Khayat R, Ekiert DC, Lee JH, Metlagel Z, Bujny MV, Jongeneelen M, van der Vlugt R, Lamrani M, Korse HJ, Geelen E, Sahin Ö, ... ... Goudsmit J, et al. Highly conserved protective epitopes on influenza B viruses. Science (New York, N.Y.). 337: 1343-8. PMID 22878502 DOI: 10.1126/Science.1222908 |
0.322 |
|
| 2012 |
Bolton DL, Santra S, Swett-Tapia C, Custers J, Song K, Balachandran H, Mach L, Naim H, Kozlowski PA, Lifton M, Goudsmit J, Letvin N, Roederer M, Radoševi? K. Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates. Vaccine. 30: 5991-8. PMID 22732429 DOI: 10.1016/J.Vaccine.2012.06.029 |
0.316 |
|
| 2012 |
Kostense S, Moore S, Companjen A, Bakker AB, Marissen WE, von Eyben R, Weverling GJ, Hanlon C, Goudsmit J. Validation of the rapid fluorescent focus inhibition test for rabies virus-neutralizing antibodies in clinical samples. Antimicrobial Agents and Chemotherapy. 56: 3524-30. PMID 22547629 DOI: 10.1128/Aac.06179-11 |
0.385 |
|
| 2012 |
Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, Lynch DM, Iampietro MJ, SanMiguel A, Seaman MS, Ferrari G, Forthal DN, Ourmanov I, Hirsch VM, Carville A, Mansfield KG, ... ... Goudsmit J, et al. Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature. 482: 89-93. PMID 22217938 DOI: 10.1038/Nature10766 |
0.413 |
|
| 2012 |
Walsh S, Seaman, Johnson J, Tucker R, Krause K, Weijtens M, Pau M, Goudsmit J, Dolin R, Barouch D, Baden L. First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine Retrovirology. 9: 1-1. DOI: 10.1186/1742-4690-9-S2-O52 |
0.404 |
|
| 2011 |
Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, Ophorst C, Cox F, Korse HJ, Brandenburg B, Vogels R, Brakenhoff JP, Kompier R, Koldijk MH, Cornelissen LA, ... ... Goudsmit J, et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science (New York, N.Y.). 333: 843-50. PMID 21737702 DOI: 10.1126/Science.1204839 |
0.336 |
|
| 2011 |
Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S, Ng'ang'a D, Brandariz KL, Abbink P, Sinangil F, de Bruyn G, Gray GE, Roux S, Bekker LG, ... ... Goudsmit J, et al. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine. 29: 5203-9. PMID 21619905 DOI: 10.1016/J.Vaccine.2011.05.025 |
0.306 |
|
| 2011 |
Kostense S, Mommaas B, Hendriks J, Verhoeven M, Ter Haak M, Tirion F, Wiesken E, Pau MG, Radosevic K, Goudsmit J. A peptide-based Plasmodium falciparum circumsporozoite assay to test for serum antibody responses to pre-erythrocyte malaria vaccines. Clinical and Vaccine Immunology : Cvi. 18: 776-82. PMID 21411600 DOI: 10.1128/Cvi.00547-10 |
0.316 |
|
| 2010 |
Song K, Bolton DL, Wei CJ, Wilson RL, Camp JV, Bao S, Mattapallil JJ, Herzenberg LA, Herzenberg LA, Andrews CA, Sadoff JC, Goudsmit J, Pau MG, Seder RA, Kozlowski PA, et al. Genetic immunization in the lung induces potent local and systemic immune responses. Proceedings of the National Academy of Sciences of the United States of America. 107: 22213-8. PMID 21135247 DOI: 10.1073/Pnas.1015536108 |
0.333 |
|
| 2010 |
Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, Koup RA, Roederer M, Bailer R, Mascola JR, Pau MG, ... ... Goudsmit J, et al. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine. 29: 304-13. PMID 21034824 DOI: 10.1016/J.Vaccine.2010.10.037 |
0.353 |
|
| 2010 |
Kaufmann B, Vogt MR, Goudsmit J, Holdaway HA, Aksyuk AA, Chipman PR, Kuhn RJ, Diamond MS, Rossmann MG. Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354. Proceedings of the National Academy of Sciences of the United States of America. 107: 18950-5. PMID 20956322 DOI: 10.1073/Pnas.1011036107 |
0.357 |
|
| 2010 |
Geisbert TW, Bailey M, Geisbert JB, Asiedu C, Roederer M, Grazia-Pau M, Custers J, Jahrling P, Goudsmit J, Koup R, Sullivan NJ. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates. Journal of Virology. 84: 10386-94. PMID 20660192 DOI: 10.1128/Jvi.00594-10 |
0.325 |
|
| 2010 |
Ayele W, Mekonnen Y, Messele T, Mengistu Y, Tsegaye A, Bakker M, Berkhout B, Dorigo-Zetsma W, Wolday D, Goudsmit J, Coutinho R, de Baar M, Paxton WA, Pollakis G. Differences in HIV type 1 RNA plasma load profile of closely related cocirculating Ethiopian subtype C strains: C and C'. Aids Research and Human Retroviruses. 26: 805-13. PMID 20624072 DOI: 10.1089/Aid.2009.0152 |
0.399 |
|
| 2010 |
Friesen RH, Koudstaal W, Koldijk MH, Weverling GJ, Brakenhoff JP, Lenting PJ, Stittelaar KJ, Osterhaus AD, Kompier R, Goudsmit J. New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets. Plos One. 5: e9106. PMID 20161706 DOI: 10.1371/Journal.Pone.0009106 |
0.308 |
|
| 2009 |
Koudstaal W, Koldijk MH, Brakenhoff JP, Cornelissen LA, Weverling GJ, Friesen RH, Goudsmit J. Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivir. The Journal of Infectious Diseases. 200: 1870-3. PMID 19911992 DOI: 10.1086/648378 |
0.343 |
|
| 2009 |
Heeregrave EJ, Geels MJ, Brenchley JM, Baan E, Ambrozak DR, van der Sluis RM, Bennemeer R, Douek DC, Goudsmit J, Pollakis G, Koup RA, Paxton WA. Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets. Virology. 393: 24-32. PMID 19698967 DOI: 10.1016/J.Virol.2009.07.011 |
0.391 |
|
| 2009 |
Rodríguez A, Mintardjo R, Tax D, Gillissen G, Custers J, Pau MG, Klap J, Santra S, Balachandran H, Letvin NL, Goudsmit J, Radosevi? K. Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys. Vaccine. 27: 6226-33. PMID 19686691 DOI: 10.1016/J.Vaccine.2009.07.106 |
0.323 |
|
| 2009 |
O'Brien KL, Liu J, King SL, Sun YH, Schmitz JE, Lifton MA, Hutnick NA, Betts MR, Dubey SA, Goudsmit J, Shiver JW, Robertson MN, Casimiro DR, Barouch DH. Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans. Nature Medicine. 15: 873-5. PMID 19620961 DOI: 10.1038/Nm.1991 |
0.422 |
|
| 2009 |
Ayele W, Assefa T, Lulseged S, Tegbaru B, Berhanu H, Tamene W, Ahmedin Z, Tensai BW, Tafesse M, Goudsmit J, Berkhout B, Paxton WA, Debaar MP, Messele T, Pollakis G. RNA detection and subtype C assessment of HIV-1 in infants with diarrhea in Ethiopia. The Open Aids Journal. 3: 19-23. PMID 19554214 DOI: 10.2174/1874613600903010019 |
0.427 |
|
| 2009 |
Barouch DH, Liu J, Lynch DM, O'Brien KL, La Porte A, Simmons NL, Riggs AM, Clark S, Abbink P, Montefiori DC, Landucci G, Forthal DN, Self SG, Carville A, Mansfield K, ... Goudsmit J, et al. Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys. Journal of Virology. 83: 9584-90. PMID 19553307 DOI: 10.1128/Jvi.00821-09 |
0.343 |
|
| 2009 |
Radosevi? K, Rodriguez A, Lemckert A, Goudsmit J. Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects. Expert Review of Vaccines. 8: 577-92. PMID 19397415 DOI: 10.1586/Erv.09.14 |
0.309 |
|
| 2009 |
Vogt MR, Moesker B, Goudsmit J, Jongeneelen M, Austin SK, Oliphant T, Nelson S, Pierson TC, Wilschut J, Throsby M, Diamond MS. Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step. Journal of Virology. 83: 6494-507. PMID 19386704 DOI: 10.1128/Jvi.00286-09 |
0.375 |
|
| 2009 |
Adams WC, Bond E, Havenga MJ, Holterman L, Goudsmit J, Karlsson Hedestam GB, Koup RA, Loré K. Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN. The Journal of General Virology. 90: 1600-10. PMID 19282435 DOI: 10.1099/Vir.0.008342-0 |
0.3 |
|
| 2009 |
Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, Goudsmit J, Wilson IA. Antibody recognition of a highly conserved influenza virus epitope. Science (New York, N.Y.). 324: 246-51. PMID 19251591 DOI: 10.1126/Science.1171491 |
0.341 |
|
| 2009 |
Liu J, O'Brien KL, Lynch DM, Simmons NL, La Porte A, Riggs AM, Abbink P, Coffey RT, Grandpre LE, Seaman MS, Landucci G, Forthal DN, Montefiori DC, Carville A, Mansfield KG, ... ... Goudsmit J, et al. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature. 457: 87-91. PMID 18997770 DOI: 10.1038/Nature07469 |
0.376 |
|
| 2009 |
Maxfield LF, King SL, Riggs AM, Dilan R, LaPorte A, Hural J, McElrath MJ, Goudsmit J, Barouch DH. P17-22. Impact of rare adenovirus seroprevalence on HIV-1 acquisition in the Step study Retrovirology. 6: P304. DOI: 10.1186/1742-4690-6-S3-P304 |
0.436 |
|
| 2009 |
Baden LR, Dolin R, O'Brien KL, Abbink P, La Porte A, Seaman MS, Choi E, Tucker R, Weitjens M, Pau MG, Goudsmit J, Barouch DH. OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector Retrovirology. 6: O36. DOI: 10.1186/1742-4690-6-S3-O36 |
0.404 |
|
| 2008 |
Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, Cinatl J, ter Meulen J, Lasters I, Carsetti R, Peiris M, ... ... Goudsmit J, et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. Plos One. 3: e3942. PMID 19079604 DOI: 10.1371/Journal.Pone.0003942 |
0.345 |
|
| 2008 |
Bakker AB, Python C, Kissling CJ, Pandya P, Marissen WE, Brink MF, Lagerwerf F, Worst S, van Corven E, Kostense S, Hartmann K, Weverling GJ, Uytdehaag F, Herzog C, Briggs DJ, ... ... Goudsmit J, et al. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. Vaccine. 26: 5922-7. PMID 18804136 DOI: 10.1016/J.Vaccine.2008.08.050 |
0.316 |
|
| 2008 |
Bart PA, Goodall R, Barber T, Harari A, Guimaraes-Walker A, Khonkarly M, Sheppard NC, Bangala Y, Frachette MJ, Wagner R, Liljeström P, Kraehenbuhl JP, Girard M, Goudsmit J, Esteban M, et al. EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium. Vaccine. 26: 3153-61. PMID 18502002 DOI: 10.1016/J.Vaccine.2008.03.083 |
0.404 |
|
| 2008 |
Kaufman DR, Goudsmit J, Holterman L, Ewald BA, Denholtz M, Devoy C, Giri A, Grandpre LE, Heraud JM, Franchini G, Seaman MS, Havenga MJ, Barouch DH. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice. Journal of Virology. 82: 6829-37. PMID 18448519 DOI: 10.1128/Jvi.00353-08 |
0.363 |
|
| 2008 |
Liu J, Ewald BA, Lynch DM, Denholtz M, Abbink P, Lemckert AA, Carville A, Mansfield KG, Havenga MJ, Goudsmit J, Barouch DH. Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys. Journal of Virology. 82: 4844-52. PMID 18337575 DOI: 10.1128/Jvi.02616-07 |
0.33 |
|
| 2008 |
Rodríguez A, Goudsmit J, Companjen A, Mintardjo R, Gillissen G, Tax D, Sijtsma J, Weverling GJ, Holterman L, Lanar DE, Havenga MJ, Radosevic K. Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1. Infection and Immunity. 76: 1709-18. PMID 18212075 DOI: 10.1128/Iai.01614-07 |
0.312 |
|
| 2007 |
Vogels R, Zuijdgeest D, van Meerendonk M, Companjen A, Gillissen G, Sijtsma J, Melis I, Holterman L, Radosevic K, Goudsmit J, Havenga MJ. High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector. The Journal of General Virology. 88: 2915-24. PMID 17947512 DOI: 10.1099/Vir.0.83119-0 |
0.331 |
|
| 2007 |
Koldijk MH, Bogaards JA, Kostense S, de Vocht M, Gijsbers L, Ter Haak M, Ophorst C, Brakenhoff JP, Weverling GJ, Guichoux JY, Uytdehaag F, Lewis J, Goudsmit J, Marzio G. A sensitive cell-based assay for the detection of residual infectious West Nile virus. Vaccine. 25: 6872-81. PMID 17707954 DOI: 10.1016/J.Vaccine.2007.07.011 |
0.332 |
|
| 2007 |
Throsby M, Ter Meulen J, Geuijen C, Goudsmit J, de Kruif J. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development. Expert Review of Vaccines. 6: 183-91. PMID 17408368 DOI: 10.1586/14760584.6.2.183 |
0.352 |
|
| 2007 |
Nabatov AA, Masharsky AE, Verevochkin SV, Emelyanov AV, Lukashov VV, Heimer R, Ryder RW, Goudsmit J, Kozlov AP. The rate of epidemiological and virological changes during the transition from nascent to concentrated HIV epidemic stage in the former Soviet Union countries. Aids Research and Human Retroviruses. 23: 183-92. PMID 17331025 DOI: 10.1089/Aid.2006.0006 |
0.45 |
|
| 2007 |
Stewart VA, McGrath SM, Dubois PM, Pau MG, Mettens P, Shott J, Cobb M, Burge JR, Larson D, Ware LA, Demoitie MA, Weverling GJ, Bayat B, Custers JH, Dubois MC, ... ... Goudsmit J, et al. Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone. Infection and Immunity. 75: 2283-90. PMID 17307942 DOI: 10.1128/Iai.01879-06 |
0.317 |
|
| 2007 |
Bogaards JA, Putter H, Jan Weverling G, Ter Meulen J, Goudsmit J. The potential of targeted antibody prophylaxis in SARS outbreak control: a mathematic analysis. Travel Medicine and Infectious Disease. 5: 70-8. PMID 17298911 DOI: 10.1016/J.Tmaid.2006.01.007 |
0.313 |
|
| 2007 |
Ayele W, Schuurman R, Messele T, Dorigo-Zetsma W, Mengistu Y, Goudsmit J, Paxton WA, de Baar MP, Pollakis G. Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden. Journal of Clinical Microbiology. 45: 891-6. PMID 17251400 DOI: 10.1128/Jcm.01919-06 |
0.341 |
|
| 2007 |
de Kruif J, Bakker AB, Marissen WE, Kramer RA, Throsby M, Rupprecht CE, Goudsmit J. A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis. Annual Review of Medicine. 58: 359-68. PMID 16886905 DOI: 10.1146/Annurev.Med.58.061705.145053 |
0.347 |
|
| 2006 |
Lukashov VV, Lazovskaia NV, Karamov EV, Adema KW, Gasich EL, Baan E, Titov LP, Goudsmit J, Eremin VF. [The molecular epidemiology of HIV-1 in Belarus in (1996-2004): a predominance of subtype A variants and circulation of subtype B variants]. Voprosy Virusologii. 51: 22-6. PMID 17214078 |
0.358 |
|
| 2006 |
Thorner AR, Lemckert AA, Goudsmit J, Lynch DM, Ewald BA, Denholtz M, Havenga MJ, Barouch DH. Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity. Journal of Virology. 80: 12009-16. PMID 17035318 DOI: 10.1128/Jvi.01749-06 |
0.326 |
|
| 2006 |
Thorner AR, Vogels R, Kaspers J, Weverling GJ, Holterman L, Lemckert AA, Dilraj A, McNally LM, Jeena PM, Jepsen S, Abbink P, Nanda A, Swanson PE, Bates AT, O'Brien KL, ... ... Goudsmit J, et al. Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa. Journal of Clinical Microbiology. 44: 3781-3. PMID 17021110 DOI: 10.1128/Jcm.01249-06 |
0.358 |
|
| 2006 |
Lemckert AA, Grimbergen J, Smits S, Hartkoorn E, Holterman L, Berkhout B, Barouch DH, Vogels R, Quax P, Goudsmit J, Havenga MJ. Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity. The Journal of General Virology. 87: 2891-9. PMID 16963747 DOI: 10.1099/Vir.0.82079-0 |
0.316 |
|
| 2006 |
Havenga M, Vogels R, Zuijdgeest D, Radosevic K, Mueller S, Sieuwerts M, Weichold F, Damen I, Kaspers J, Lemckert A, van Meerendonk M, van der Vlugt R, Holterman L, Hone D, Skeiky Y, ... ... Goudsmit J, et al. Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells. The Journal of General Virology. 87: 2135-43. PMID 16847108 DOI: 10.1099/Vir.0.81956-0 |
0.312 |
|
| 2006 |
Throsby M, Geuijen C, Goudsmit J, Bakker AQ, Korimbocus J, Kramer RA, Clijsters-van der Horst M, de Jong M, Jongeneelen M, Thijsse S, Smit R, Visser TJ, Bijl N, Marissen WE, Loeb M, et al. Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus. Journal of Virology. 80: 6982-92. PMID 16809304 DOI: 10.1128/Jvi.00551-06 |
0.364 |
|
| 2006 |
ter Meulen J, van den Brink EN, Poon LL, Marissen WE, Leung CS, Cox F, Cheung CY, Bakker AQ, Bogaards JA, van Deventer E, Preiser W, Doerr HW, Chow VT, de Kruif J, Peiris JS, ... Goudsmit J, et al. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. Plos Medicine. 3: e237. PMID 16796401 DOI: 10.1371/Journal.Pmed.0030237 |
0.36 |
|
| 2006 |
Sullivan NJ, Geisbert TW, Geisbert JB, Shedlock DJ, Xu L, Lamoreaux L, Custers JH, Popernack PM, Yang ZY, Pau MG, Roederer M, Koup RA, Goudsmit J, Jahrling PB, Nabel GJ. Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs. Plos Medicine. 3: e177. PMID 16683867 DOI: 10.1371/Journal.Pmed.0030177 |
0.36 |
|
| 2006 |
Roberts DM, Nanda A, Havenga MJ, Abbink P, Lynch DM, Ewald BA, Liu J, Thorner AR, Swanson PE, Gorgone DA, Lifton MA, Lemckert AA, Holterman L, Chen B, Dilraj A, ... ... Goudsmit J, et al. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature. 441: 239-43. PMID 16625206 DOI: 10.1038/Nature04721 |
0.351 |
|
| 2006 |
Goudsmit J, Marissen WE, Weldon WC, Niezgoda M, Hanlon CA, Rice AB, Kruif Jd, Dietzschold B, Bakker AB, Rupprecht CE. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin. The Journal of Infectious Diseases. 193: 796-801. PMID 16479514 DOI: 10.1086/500470 |
0.34 |
|
| 2006 |
Bogaards JA, Weverling GJ, Zwinderman AH, Bossuyt PM, Goudsmit J. Plasma HIV-1 RNA to guide patient selection for antiretroviral therapy in resource-poor settings: efficiency related to active case finding. Journal of Acquired Immune Deficiency Syndromes (1999). 41: 232-7. PMID 16394857 DOI: 10.1097/01.Qai.0000179457.46809.42 |
0.419 |
|
| 2006 |
Ophorst OJ, Radosevi? K, Havenga MJ, Pau MG, Holterman L, Berkhout B, Goudsmit J, Tsuji M. Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice. Infection and Immunity. 74: 313-20. PMID 16368986 DOI: 10.1128/Iai.74.1.313-320.2006 |
0.334 |
|
| 2006 |
Geels MJ, Jansen CA, Baan E, De Cuyper IM, van Schijndel GJ, Schuitemaker H, Goudsmit J, Pollakis G, Miedema F, Paxton WA, van Baarle D. CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals. Virology. 345: 209-19. PMID 16246391 DOI: 10.1016/J.Virol.2005.09.023 |
0.453 |
|
| 2006 |
Lemckert A, Grimbergen J, Thorner A, Vogels R, Quax P, Goudsmit J, Barouch D, Havenga M. 596. A Novel Replication Incompetent Human Subgroup D Adenoviral Vector Based on Type 49: Manufacture on PER.C6®, Cell Tropism and Immunogenicity Molecular Therapy. 13. DOI: 10.1016/J.Ymthe.2006.08.670 |
0.318 |
|
| 2005 |
Nanda A, Lynch DM, Goudsmit J, Lemckert AA, Ewald BA, Sumida SM, Truitt DM, Abbink P, Kishko MG, Gorgone DA, Lifton MA, Shen L, Carville A, Mansfield KG, Havenga MJ, et al. Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys. Journal of Virology. 79: 14161-8. PMID 16254351 DOI: 10.1128/Jvi.79.22.14161-14168.2005 |
0.348 |
|
| 2005 |
Geels MJ, Dubey SA, Anderson K, Baan E, Bakker M, Pollakis G, Paxton WA, Shiver JW, Goudsmit J. Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation. Journal of Virology. 79: 11247-58. PMID 16103177 DOI: 10.1128/Jvi.79.17.11247-11258.2005 |
0.394 |
|
| 2005 |
Ayele W, Baar MP, Goudsmit J, Kliphuis A, Tilahun T, Dorigo-Zetsma W, Wolday D, Abebe A, Mengistu Y, Pollakis G. Surveillance technology for HIV-1 subtype C in Ethiopia: an env-based NASBA molecular beacon assay to discriminate between subcluster C and C'. Journal of Virological Methods. 130: 22-9. PMID 16040135 DOI: 10.1016/J.Jviromet.2005.05.028 |
0.303 |
|
| 2005 |
Lemckert AA, Sumida SM, Holterman L, Vogels R, Truitt DM, Lynch DM, Nanda A, Ewald BA, Gorgone DA, Lifton MA, Goudsmit J, Havenga MJ, Barouch DH. Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity. Journal of Virology. 79: 9694-701. PMID 16014931 DOI: 10.1128/Jvi.79.15.9694-9701.2005 |
0.31 |
|
| 2005 |
Bakker AB, Marissen WE, Kramer RA, Rice AB, Weldon WC, Niezgoda M, Hanlon CA, Thijsse S, Backus HH, de Kruif J, Dietzschold B, Rupprecht CE, Goudsmit J. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants. Journal of Virology. 79: 9062-8. PMID 15994800 DOI: 10.1128/Jvi.79.14.9062-9068.2005 |
0.331 |
|
| 2005 |
Geuijen CA, Clijsters-van der Horst M, Cox F, Rood PM, Throsby M, Jongeneelen MA, Backus HH, van Deventer E, Kruisbeek AM, Goudsmit J, de Kruif J. Affinity ranking of antibodies using flow cytometry: application in antibody phage display-based target discovery. Journal of Immunological Methods. 302: 68-77. PMID 15992810 DOI: 10.1016/J.Jim.2005.04.016 |
0.311 |
|
| 2005 |
van der Kuyl AC, Polstra AM, van den Burg R, Jan Weverling G, Goudsmit J, Cornelissen M. Cytomegalovirus and human herpesvirus 8 DNA detection in peripheral blood monocytic cells of AIDS patients: correlations with the presence of Kaposi's sarcoma and CMV disease. Journal of Medical Virology. 76: 541-6. PMID 15977227 DOI: 10.1002/Jmv.20396 |
0.335 |
|
| 2005 |
Kramer RA, Marissen WE, Goudsmit J, Visser TJ, Clijsters-Van der Horst M, Bakker AQ, de Jong M, Jongeneelen M, Thijsse S, Backus HH, Rice AB, Weldon WC, Rupprecht CE, Dietzschold B, Bakker AB, et al. The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries. European Journal of Immunology. 35: 2131-45. PMID 15971273 DOI: 10.1002/Eji.200526134 |
0.36 |
|
| 2005 |
Sumida SM, Truitt DM, Lemckert AA, Vogels R, Custers JH, Addo MM, Lockman S, Peter T, Peyerl FW, Kishko MG, Jackson SS, Gorgone DA, Lifton MA, Essex M, Walker BD, ... Goudsmit J, et al. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein. Journal of Immunology (Baltimore, Md. : 1950). 174: 7179-85. PMID 15905562 DOI: 10.4049/Jimmunol.174.11.7179 |
0.351 |
|
| 2005 |
Bogaards JA, van Ballegooijen WM, Jan Weverling G, Boerlijst MC, Goudsmit J. Is population-level perversity a likely outcome of mass vaccination against HIV? The Lancet. Infectious Diseases. 5: 254; author reply 25. PMID 15854875 DOI: 10.1016/S1473-3099(05)70089-X |
0.461 |
|
| 2005 |
Marissen WE, Kramer RA, Rice A, Weldon WC, Niezgoda M, Faber M, Slootstra JW, Meloen RH, Clijsters-van der Horst M, Visser TJ, Jongeneelen M, Thijsse S, Throsby M, de Kruif J, Rupprecht CE, ... ... Goudsmit J, et al. Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis. Journal of Virology. 79: 4672-8. PMID 15795253 DOI: 10.1128/Jvi.79.8.4672-4678.2005 |
0.35 |
|
| 2005 |
van den Brink EN, Ter Meulen J, Cox F, Jongeneelen MA, Thijsse A, Throsby M, Marissen WE, Rood PM, Bakker AB, Gelderblom HR, Martina BE, Osterhaus AD, Preiser W, Doerr HW, de Kruif J, ... Goudsmit J, et al. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. Journal of Virology. 79: 1635-44. PMID 15650189 DOI: 10.1128/Jvi.79.3.1635-1644.2005 |
0.31 |
|
| 2005 |
Barouch D, Letvin N, Havenga M, Goudsmit J. Novel Adenovirus Vector-Based Vaccines for HIV Retrovirology. 2: 1-1. DOI: 10.1186/1742-4690-2-S1-S60 |
0.424 |
|
| 2004 |
Holterman L, Vogels R, van der Vlugt R, Sieuwerts M, Grimbergen J, Kaspers J, Geelen E, van der Helm E, Lemckert A, Gillissen G, Verhaagh S, Custers J, Zuijdgeest D, Berkhout B, Bakker M, ... ... Goudsmit J, et al. Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5. Journal of Virology. 78: 13207-15. PMID 15542673 DOI: 10.1128/Jvi.78.23.13207-13215.2004 |
0.332 |
|
| 2004 |
Polstra AM, Cornelissen M, Goudsmit J, van der Kuyl AC. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis. Journal of Medical Virology. 74: 390-6. PMID 15368522 DOI: 10.1002/Jmv.20192 |
0.31 |
|
| 2004 |
Lemckert AA, Goudsmit J, Barouch DH. Challenges in the search for an HIV vaccine. European Journal of Epidemiology. 19: 513-6. PMID 15330122 DOI: 10.1023/B:Ejep.0000032423.87658.68 |
0.379 |
|
| 2004 |
ter Meulen J, Bakker AB, van den Brink EN, Weverling GJ, Martina BE, Haagmans BL, Kuiken T, de Kruif J, Preiser W, Spaan W, Gelderblom HR, Goudsmit J, Osterhaus AD. Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet (London, England). 363: 2139-41. PMID 15220038 DOI: 10.1016/S0140-6736(04)16506-9 |
0.375 |
|
| 2004 |
Kostense S, Koudstaal W, Sprangers M, Weverling GJ, Penders G, Helmus N, Vogels R, Bakker M, Berkhout B, Havenga M, Goudsmit J. Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector. Aids (London, England). 18: 1213-6. PMID 15166541 DOI: 10.1097/00002030-200405210-00019 |
0.41 |
|
| 2004 |
Barouch DH, Pau MG, Custers JH, Koudstaal W, Kostense S, Havenga MJ, Truitt DM, Sumida SM, Kishko MG, Arthur JC, Korioth-Schmitz B, Newberg MH, Gorgone DA, Lifton MA, Panicali DL, ... ... Goudsmit J, et al. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. Journal of Immunology (Baltimore, Md. : 1950). 172: 6290-7. PMID 15128818 DOI: 10.4049/Jimmunol.172.10.6290 |
0.313 |
|
| 2004 |
Mercier S, Verhaagh S, Goudsmit J, Lemckert A, Monteil M, Havenga M, Eloit M. Adenovirus fibre exchange alters cell tropism in vitro but not transgene-specific T CD8+ immune responses in vivo. The Journal of General Virology. 85: 1227-36. PMID 15105539 DOI: 10.1099/Vir.0.79846-0 |
0.304 |
|
| 2004 |
Ayele W, Pollakis G, Abebe A, Fisseha B, Tegbaru B, Tesfaye G, Mengistu Y, Wolday D, van Gemen B, Goudsmit J, Dorigo-Zetsma W, de Baar MP. Development of a nucleic acid sequence-based amplification assay that uses gag-based molecular beacons to distinguish between human immunodeficiency virus type 1 subtype C and C' infections in Ethiopia. Journal of Clinical Microbiology. 42: 1534-41. PMID 15071000 DOI: 10.1128/Jcm.42.4.1534-1541.2004 |
0.399 |
|
| 2004 |
Cayabyab M, Rohne D, Pollakis G, Mische C, Messele T, Abebe A, Etemad-Moghadam B, Yang P, Henson S, Axthelm M, Goudsmit J, Letvin NL, Sodroski J. Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate. Aids Research and Human Retroviruses. 20: 27-40. PMID 15000696 DOI: 10.1089/088922204322749477 |
0.447 |
|
| 2004 |
Pollakis G, Abebe A, Kliphuis A, Chalaby MI, Bakker M, Mengistu Y, Brouwer M, Goudsmit J, Schuitemaker H, Paxton WA. Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals. Journal of Virology. 78: 2841-52. PMID 14990703 DOI: 10.1128/Jvi.78.6.2841-2852.2004 |
0.402 |
|
| 2004 |
Sumida SM, Truitt DM, Kishko MG, Arthur JC, Jackson SS, Gorgone DA, Lifton MA, Koudstaal W, Pau MG, Kostense S, Havenga MJ, Goudsmit J, Letvin NL, Barouch DH. Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors. Journal of Virology. 78: 2666-73. PMID 14990686 DOI: 10.1128/Jvi.78.6.2666-2673.2004 |
0.325 |
|
| 2004 |
Slager EH, van der Minne CE, Goudsmit J, van Oers JM, Kostense S, Havenga MJ, Osanto S, Griffioen M. Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber. Cancer Gene Therapy. 11: 227-36. PMID 14726960 DOI: 10.1038/Sj.Cgt.7700674 |
0.312 |
|
| 2004 |
Lemckert AAC, Verhaagh S, Goudsmit J. HIV: verleden, heden en toekomst Bijblijven. 20: 105-109. DOI: 10.1007/BF03059764 |
0.354 |
|
| 2003 |
Pollakis G, Abebe A, Kliphuis A, De Wit TF, Fisseha B, Tegbaru B, Tesfaye G, Negassa H, Mengistu Y, Fontanet AL, Cornelissen M, Goudsmit J. Recombination of HIV type 1C (C'/C") in Ethiopia: possible link of EthHIV-1C' to subtype C sequences from the high-prevalence epidemics in India and Southern Africa. Aids Research and Human Retroviruses. 19: 999-1008. PMID 14678607 DOI: 10.1089/088922203322588350 |
0.414 |
|
| 2003 |
Geels MJ, Cornelissen M, Schuitemaker H, Anderson K, Kwa D, Maas J, Dekker JT, Baan E, Zorgdrager F, van den Burg R, van Beelen M, Lukashov VV, Fu TM, Paxton WA, van der Hoek L, ... ... Goudsmit J, et al. Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual. Journal of Virology. 77: 12430-40. PMID 14610167 DOI: 10.1128/Jvi.77.23.12430-12440.2003 |
0.469 |
|
| 2003 |
Sprangers MC, Lakhai W, Koudstaal W, Verhoeven M, Koel BF, Vogels R, Goudsmit J, Havenga MJ, Kostense S. Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors. Journal of Clinical Microbiology. 41: 5046-52. PMID 14605137 DOI: 10.1128/Jcm.41.11.5046-5052.2003 |
0.314 |
|
| 2003 |
De Baar MP, Abebe A, Kliphuis A, Tesfaye G, Goudsmit J, Pollakis G. HIV type 1 C and C' subclusters based on long terminal repeat sequences in the Ethiopian type 1 subtype C epidemic. Aids Research and Human Retroviruses. 19: 917-22. PMID 14601586 DOI: 10.1089/088922203322493094 |
0.32 |
|
| 2003 |
Bogaards JA, Goudsmit J. Meeting the immense need for HAART in resource-poor settings. The Journal of Antimicrobial Chemotherapy. 52: 743-6. PMID 14563896 DOI: 10.1093/Jac/Dkg454 |
0.426 |
|
| 2003 |
van Ballegooijen M, Bogaards JA, Weverling GJ, Boerlijst MC, Goudsmit J. AIDS vaccines that allow HIV-1 to infect and escape immunologic control: a mathematic analysis of mass vaccination. Journal of Acquired Immune Deficiency Syndromes (1999). 34: 214-20. PMID 14526211 DOI: 10.1097/00126334-200310010-00012 |
0.451 |
|
| 2003 |
Lonsdale R, Pau MG, Oerlemans M, Ophorst C, Vooys A, Havenga M, Goudsmit J, UytdeHaag F, Marzio G. A rapid method for immunotitration of influenza viruses using flow cytometry. Journal of Virological Methods. 110: 67-71. PMID 12757922 DOI: 10.1016/S0166-0934(03)00102-2 |
0.318 |
|
| 2003 |
Bogaards JA, Weverling GJ, Geskus RB, Miedema F, Lange JM, Bossuyt PM, Goudsmit J. Low versus high CD4 cell count as starting point for introduction of antiretroviral treatment in resource-poor settings: a scenario-based analysis. Antiviral Therapy. 8: 43-50. PMID 12713063 |
0.394 |
|
| 2003 |
Cornelissen M, van der Kuyl AC, van den Burg R, Zorgdrager F, van Noesel CJ, Goudsmit J. Gene expression profile of AIDS-related Kaposi's sarcoma. Bmc Cancer. 3: 7. PMID 12697073 DOI: 10.1186/1471-2407-3-7 |
0.464 |
|
| 2003 |
Geskus RB, Miedema FA, Goudsmit J, Reiss P, Schuitemaker H, Coutinho RA. Prediction of residual time to AIDS and death based on markers and cofactors. Journal of Acquired Immune Deficiency Syndromes (1999). 32: 514-21. PMID 12679703 DOI: 10.1097/00126334-200304150-00008 |
0.423 |
|
| 2003 |
Lukashov VV, Goudsmit J. Recent evolutionary history of HIV-1 subtype B - Rebuttal Journal of Molecular Evolution. 56: 645-647. DOI: 10.1007/s00239-002-2439-5 |
0.326 |
|
| 2002 |
Babiker AG, Andersson R, Antunes F, Breckenridge A, Brosgart C, Clezy K, Cooper D, Coakley D, Dally LG, Darbyshire JH, Floridia M, Fry J, Gatell J, Gazzard B, Goebel FD, ... Goudsmit J, et al. A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: The ADHOC trial Hiv Medicine. 3: 229-238. PMID 12444940 DOI: 10.1046/J.1468-1293.2002.00111.X |
0.448 |
|
| 2002 |
Renwick N, Weverling GJ, Brouwer J, Bakker M, Schulz TF, Goudsmit J. Vascular endothelial growth factor levels in serum do not increase following HIV type 1 and HHV8 seroconversion and lack correlation with AIDS-related Kaposi's sarcoma. Aids Research and Human Retroviruses. 18: 695-8. PMID 12167275 DOI: 10.1089/088922202760072302 |
0.39 |
|
| 2002 |
Rinke de Wit TF, Tsegaye A, Wolday D, Hailu B, Aklilu M, Sanders E, Hagos M, Kliphuis A, Pollakis G, Krol A, Geskus R, Miedema F, Goudsmit J, Coutinho R, Fontanet AL. Primary HIV-1 subtype C infection in Ethiopia. Journal of Acquired Immune Deficiency Syndromes (1999). 30: 463-70. PMID 12154336 DOI: 10.1097/00126334-200208150-00001 |
0.449 |
|
| 2002 |
Renwick N, Dukers NH, Weverling GJ, Sheldon JA, Schulz TF, Prins M, Coutinho RA, Goudsmit J. Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996. The Journal of Infectious Diseases. 185: 1808-12. PMID 12085330 DOI: 10.1086/340817 |
0.39 |
|
| 2002 |
Ghani AC, Ferguson NM, Fraser C, Donnelly CA, Danner S, Reiss P, Lange J, Goudsmit J, Anderson RM, De Wolf F. Viral replication under combination antiretroviral therapy: a comparison of four different regimens. Journal of Acquired Immune Deficiency Syndromes (1999). 30: 167-76. PMID 12045679 DOI: 10.1097/00042560-200206010-00005 |
0.481 |
|
| 2002 |
Chen X, Goudsmit J, van der Kuyl AC. Lack of correlation between length variation in the DNA polymerase gamma gene CAG repeat and lactic acidosis or neuropathy during antiretroviral treatment. Aids Research and Human Retroviruses. 18: 531-4. PMID 12036482 DOI: 10.1089/088922202753747879 |
0.356 |
|
| 2002 |
Lukashov VV, Goudsmit J. Recent evolutionary history of human immunodeficiency virus type 1 subtype B: reconstruction of epidemic onset based on sequence distances to the common ancestor. Journal of Molecular Evolution. 54: 680-91. PMID 11965440 DOI: 10.1007/S00239-001-0070-5 |
0.441 |
|
| 2002 |
Goudsmit J, Bogaards JA, Jurriaans S, Schuitemaker H, Lange JM, Coutinho RA, Weverling GJ. Naturally HIV-1 seroconverters with lowest viral load have best prognosis, but in time lose control of viraemia. Aids (London, England). 16: 791-3. PMID 11964537 DOI: 10.1097/00002030-200203290-00016 |
0.616 |
|
| 2002 |
Osmanov S, Pattou C, Walker N, Schwardländer B, Esparza J, Abimiku A, Barre-Sinoussi F, Biberfield G, Birx D, Bobkov A, Von Briesen H, Dietrich U, Chappey C, Galvao-Castro B, Morgado M, ... ... Goudsmit J, et al. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000 Journal of Acquired Immune Deficiency Syndromes. 29: 184-190. PMID 11832690 |
0.367 |
|
| 2002 |
Goudsmit J, Bogaards JA, Jurriaans S, Wolf Fd, Schuitemaker H, Miedema F, Lange JMA, Coutinho RA, Weverling GJ. WITHDRAWN: Loss of control of viremia in HIV-1 seroconverters with best prognosis and lowest viral load at setpoint Vaccine. DOI: 10.1016/S0264-410X(02)00075-0 |
0.427 |
|
| 2001 |
Goudsmit J, Weverling GJ, van der Hoek L, de Ronde A, Miedema F, Coutinho RA, Lange JM, Boerlijst MC. Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains. Aids (London, England). 15: 2293-301. PMID 11698703 DOI: 10.1097/00002030-200111230-00011 |
0.408 |
|
| 2001 |
Op de Coul EL, Coutinho RA, van der Schoot A, van Doornum GJ, Lukashov VV, Goudsmit J, Cornelissen M. The impact of immigration on env HIV-1 subtype distribution among heterosexuals in the Netherlands: influx of subtype B and non-B strains. Aids (London, England). 15: 2277-86. PMID 11698701 DOI: 10.1097/00002030-200111230-00009 |
0.415 |
|
| 2001 |
Ghani AC, de Wolf F, Ferguson NM, Donnelly CA, Coutinho R, Miedema F, Goudsmit J, Anderson RM. Surrogate markers for disease progression in treated HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999). 28: 226-31. PMID 11694828 DOI: 10.1097/00042560-200111010-00004 |
0.48 |
|
| 2001 |
Renwick N, Weverling GJ, Halaby T, Portegies P, Bakker M, Schulz TF, Goudsmit J. Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complex. Aids (London, England). 15: 2165-9. PMID 11684936 DOI: 10.1097/00002030-200111090-00012 |
0.648 |
|
| 2001 |
Abebe A, Lukashov VV, Pollakis G, Kliphuis A, Fontanet AL, Goudsmit J, de Wit TF. Timing of the HIV-1 subtype C epidemic in Ethiopia based on early virus strains and subsequent virus diversification. Aids (London, England). 15: 1555-61. PMID 11504988 DOI: 10.1097/00002030-200108170-00013 |
0.464 |
|
| 2001 |
Notermans DW, de Jong JJ, Goudsmit J, Bakker M, Roos MT, Nijholt L, Cremers J, Hellings JA, Danner SA, de Ronde A. Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses. Aids Research and Human Retroviruses. 17: 1003-8. PMID 11485617 DOI: 10.1089/088922201300343681 |
0.455 |
|
| 2001 |
de Wit TF, Sanders EJ, Fontanet AL, Goudsmit J, Miedema F, Coutinho RA. [Results from the 'Ethiopia-Netherlands AIDS Research Project'; 1995-2000]. Nederlands Tijdschrift Voor Geneeskunde. 145: 1236-40. PMID 11455688 |
0.385 |
|
| 2001 |
Lukashov VV, Huismans R, Jebbink MF, Danner SA, de Boer RJ, Goudsmit J. Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs. Aids Research and Human Retroviruses. 17: 807-18. PMID 11429122 DOI: 10.1089/088922201750252007 |
0.385 |
|
| 2001 |
van Praag RM, Prins JM, Roos MT, Schellekens PT, Ten Berge IJ, Yong SL, Schuitemaker H, Eerenberg AJ, Jurriaans S, de Wolf F, Fox CH, Goudsmit J, Miedema F, Lange JM. OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion. Journal of Clinical Immunology. 21: 218-26. PMID 11403229 DOI: 10.1023/A:1011091300321 |
0.34 |
|
| 2001 |
Abebe A, Lukashov VV, Rinke De Wit TF, Fisseha B, Tegbaru B, Kliphuis A, Tesfaye G, Negassa H, Fontanet AL, Goudsmit J, Pollakis G. Timing of the introduction into Ethiopia of subcluster C' of HIV type 1 subtype C. Aids Research and Human Retroviruses. 17: 657-61. PMID 11375063 DOI: 10.1089/088922201300119770 |
0.407 |
|
| 2001 |
Barre-Sinoussi F, Berkley S, Bhamarapravati N, Birx D, Bloom B, Carvalheiro J, Ganguly N, Johnston M, Kazatchkine M, Makgoba WM, Monico SM, Nathanson N, Schild G, Wigzell H, Yamasaki S, ... ... Goudsmit J, et al. Approaches to the development of broadly protective HIV vaccines: Challenges posed by the genetic, biological and antigenic variability of HIV-1 Aids. 15: W1-W25. PMID 11371709 DOI: 10.1097/00002030-200104130-00030 |
0.345 |
|
| 2001 |
de Baar MP, Timmermans EC, Bakker M, de Rooij E, van Gemen B, Goudsmit J. One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AG. Journal of Clinical Microbiology. 39: 1895-902. PMID 11326010 DOI: 10.1128/Jcm.39.5.1895-1902.2001 |
0.469 |
|
| 2001 |
Renwick N, Weverling GJ, Schulz T, Goudsmit J. Timing of human immunodeficiency virus type 1 and human herpesvirus 8 infections and length of the Kaposi's sarcoma-free period in coinfected persons. The Journal of Infectious Diseases. 183: 1427. PMID 11294681 DOI: 10.1086/319875 |
0.356 |
|
| 2001 |
de Baar MP, van Dooren MW, de Rooij E, Bakker M, van Gemen B, Goudsmit J, de Ronde A. Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O. Journal of Clinical Microbiology. 39: 1378-84. PMID 11283059 DOI: 10.1128/Jcm.39.4.1378-1384.2001 |
0.46 |
|
| 2001 |
Pollakis G, Kang S, Kliphuis A, Chalaby MI, Goudsmit J, Paxton WA. N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. The Journal of Biological Chemistry. 276: 13433-41. PMID 11278567 DOI: 10.1074/Jbc.M009779200 |
0.436 |
|
| 2001 |
Dukers NH, Goudsmit J, de Wit JB, Prins M, Weverling GJ, Coutinho RA. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. Aids (London, England). 15: 369-78. PMID 11273217 DOI: 10.1097/00002030-200102160-00010 |
0.324 |
|
| 2001 |
Lukashov VV, Goudsmit J. Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses. Journal of Virology. 75: 2729-40. PMID 11222696 DOI: 10.1128/Jvi.75.6.2729-2740.2001 |
0.33 |
|
| 2001 |
Op de Coul EL, Prins M, Cornelissen M, van der Schoot A, Boufassa F, Brettle RP, Hernández-Aguado L, Schiffer V, McMenamin J, Rezza G, Robertson R, Zangerle R, Goudsmit J, Coutinho RA, Lukashov VV, et al. Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997. Aids (London, England). 15: 257-66. PMID 11216936 DOI: 10.1097/00002030-200101260-00017 |
0.392 |
|
| 2001 |
de Ronde A, van Dooren M, van Der Hoek L, Bouwhuis D, de Rooij E, van Gemen B, de Boer R, Goudsmit J. Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus. Journal of Virology. 75: 595-602. PMID 11134272 DOI: 10.1128/Jvi.75.2.595-602.2001 |
0.438 |
|
| 2000 |
Putter H, Prins JM, Jurriaans S, Roos M, Ferguson NM, van Praag R, van der Hoek L, Schuitemaker H, Anderson RM, Goudsmit J, Lange JM, de Wolf F. Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection. Aids (London, England). 14: 2831-9. PMID 11153664 DOI: 10.1097/00002030-200012220-00004 |
0.443 |
|
| 2000 |
Gisolf EH, van Praag RM, Jurriaans S, Portegies P, Goudsmit J, Danner SA, Lange JM, Prins JM. Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 25: 426-33. PMID 11141242 DOI: 10.1097/00042560-200012150-00007 |
0.683 |
|
| 2000 |
Lukashov VV, de Ronde A, de Jong JJ, Goudsmit J. Epidemiology of HIV-1 and emerging problems. International Journal of Antimicrobial Agents. 16: 463-6. PMID 11118859 DOI: 10.1016/S0924-8579(00)00276-4 |
0.416 |
|
| 2000 |
Abebe A, Pollakis G, Fontanet AL, Fisseha B, Tegbaru B, Kliphuis A, Tesfaye G, Negassa H, Cornelissen M, Goudsmit J, Rinke de Wit TF. Identification of a genetic subcluster of HIV type 1 subtype C (C') widespread in Ethiopia. Aids Research and Human Retroviruses. 16: 1909-14. PMID 11118076 DOI: 10.1089/08892220050195865 |
0.349 |
|
| 2000 |
de Ronde A, van Dooren M, de Rooij E, van Gemen B, Lange J, Goudsmit J. Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient. Aids (London, England). 14: 2632-3. PMID 11101087 DOI: 10.1097/00002030-200011100-00038 |
0.421 |
|
| 2000 |
Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J. Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. Journal of Virology. 74: 11972-6. PMID 11090199 DOI: 10.1128/Jvi.74.24.11972-11976.2000 |
0.463 |
|
| 2000 |
Notermans DW, de Wolf F, Oudshoorn P, Cuijpers HT, Pirillo M, Tiller FW, McClernon DR, Prins JM, Lange JM, Danner SA, Goudsmit J, Jurriaans S. Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations. Aids Research and Human Retroviruses. 16: 1507-17. PMID 11054264 DOI: 10.1089/088922200750006038 |
0.427 |
|
| 2000 |
de Baar MP, Janssens W, de Ronde A, Fransen K, Colebunders R, Kestens L, van der Groen G, Goudsmit J. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. Aids Research and Human Retroviruses. 16: 1385-94. PMID 11018858 DOI: 10.1089/08892220050140937 |
0.402 |
|
| 2000 |
van Baarle D, Hovenkamp E, Dukers NH, Renwick N, Kersten MJ, Goudsmit J, Coutinho RA, Miedema F, van Oers MH. High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission. The Journal of Infectious Diseases. 181: 2045-9. PMID 10837190 DOI: 10.1086/315521 |
0.378 |
|
| 2000 |
Fraser C, Ferguson NM, Ghani AC, Prins JM, Lange JM, Goudsmit J, Anderson RM, de Wolf F. Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs. Aids (London, England). 14: 659-69. PMID 10807189 DOI: 10.1097/00002030-200004140-00005 |
0.423 |
|
| 2000 |
Goudsmit J, Renwick N, Dukers NH, Coutinho RA, Heisterkamp S, Bakker M, Schulz TF, Cornelissen M, Weverling GJ. Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73. Proceedings of the National Academy of Sciences of the United States of America. 97: 4838-43. PMID 10781089 DOI: 10.1073/Pnas.97.9.4838 |
0.524 |
|
| 2000 |
De Baar MP, De Ronde A, Berkhout B, Cornelissen M, Van Der Horn KH, Van Der Schoot AM, De Wolf F, Lukashov VV, Goudsmit J. Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer-binding site. Aids Research and Human Retroviruses. 16: 499-504. PMID 10772536 DOI: 10.1089/088922200309160 |
0.334 |
|
| 2000 |
Op De Coul E, van den Burg R, Asjö B, Goudsmit J, Cupsa A, Pascu R, Usein C, Cornelissen M. Genetic evidence of multiple transmissions of HIV type 1 subtype F within Romania from adult blood donors to children. Aids Research and Human Retroviruses. 16: 327-36. PMID 10716370 DOI: 10.1089/088922200309205 |
0.386 |
|
| 2000 |
Bobkov AF, Lukashov VV, Goudsmit J, Weber JN. Silent mutation in the V3 region characteristic of HIV type 1 env subtype B strains from injecting drug users in the former Soviet Union. Aids Research and Human Retroviruses. 16: 291-4. PMID 10710217 DOI: 10.1089/088922200309386 |
0.425 |
|
| 2000 |
Penning M, Beld M, Goudsmit J. Peripheral blood mononuclear cells of HIV- and HCV-antibody-positive individuals contain HCV RNA but No HCV DNA despite evidence for reverse transcription of HIV RNA into DNA. Virology. 268: 12-6. PMID 10683322 DOI: 10.1006/Viro.1999.0150 |
0.416 |
|
| 2000 |
Dukers NH, Renwick N, Prins M, Geskus RB, Schulz TF, Weverling GJ, Coutinho RA, Goudsmit J. Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. American Journal of Epidemiology. 151: 213-24. PMID 10670545 DOI: 10.1093/Oxfordjournals.Aje.A010195 |
0.382 |
|
| 2000 |
Cornelissen M, van Den Burg R, Zorgdrager F, Goudsmit J. Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa. The Journal of General Virology. 81: 515-23. PMID 10644851 DOI: 10.1099/0022-1317-81-2-515 |
0.312 |
|
| 2000 |
Greensill J, Sheldon JA, Renwick NM, Beer BE, Norley S, Goudsmit J, Schulz TF. Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates? Journal of Virology. 74: 1572-7. PMID 10627572 DOI: 10.1128/Jvi.74.3.1572-1577.2000 |
0.309 |
|
| 2000 |
Heyndrickx L, Janssens W, Zekeng L, Musonda R, Anagonou S, Van der Auwera G, Coppens S, Vereecken K, De Witte K, Van Rampelbergh R, Kahindo M, Morison L, McCutchan FE, Carr JK, Albert J, ... ... Goudsmit J, et al. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities. Journal of Virology. 74: 363-70. PMID 10590125 DOI: 10.1128/Jvi.74.1.363-370.2000 |
0.481 |
|
| 2000 |
Dukers NHTM, Coutinho RA, Goudsmit J. Dukers et al. Respond to Sexual practices associated with HHV8 infection American Journal of Epidemiology. 151: 230-230. DOI: 10.1093/Oxfordjournals.Aje.A010197 |
0.314 |
|
| 2000 |
Lukashov VV, Goudsmit J. The Pros and Cons of Studying HIV Evolution in Real Time Cell. 101: 129-131. DOI: 10.1016/S0092-8674(00)80811-9 |
0.505 |
|
| 1999 |
Ferguson NM, deWolf F, Ghani AC, Fraser C, Donnelly CA, Reiss P, Lange JM, Danner SA, Garnett GP, Goudsmit J, Anderson RM. Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy. Proceedings of the National Academy of Sciences of the United States of America. 96: 15167-72. PMID 10611356 DOI: 10.1073/Pnas.96.26.15167 |
0.427 |
|
| 1999 |
Prins JM, Jurriaans S, van Praag RM, Blaak H, van Rij R, Schellekens PT, ten Berge IJ, Yong SL, Fox CH, Roos MT, de Wolf F, Goudsmit J, Schuitemaker H, Lange JM. Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy. Aids (London, England). 13: 2405-10. PMID 10597782 DOI: 10.1097/00002030-199912030-00012 |
0.464 |
|
| 1999 |
Lukashov VV, Huismans R, Rakhmanova AG, Lisitsina ZN, Akhtyrskaya NA, Vlasov NN, Melnick OB, Goudsmit J. Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections. Aids Research and Human Retroviruses. 15: 1577-83. PMID 10580409 DOI: 10.1089/088922299309874 |
0.501 |
|
| 1999 |
Holterman L, Niphuis H, ten Haaft PJ, Goudsmit J, Baskin G, Heeney JL. Specific passage of simian immunodeficiency virus from end-stage disease results in accelerated progression to AIDS in rhesus macaques. The Journal of General Virology. 80: 3089-97. PMID 10567639 DOI: 10.1099/0022-1317-80-12-3089 |
0.384 |
|
| 1999 |
Grossman Z, Polis M, Feinberg MB, Grossman Z, Levi I, Jankelevich S, Yarchoan R, Boon J, de Wolf F, Lange JM, Goudsmit J, Dimitrov DS, Paul WE. Ongoing HIV dissemination during HAART. Nature Medicine. 5: 1099-104. PMID 10502799 DOI: 10.1038/13410 |
0.487 |
|
| 1999 |
van der Kuyl AC, Dekker JT, Goudsmit J. Discovery of a new endogenous type C retrovirus (FcEV) in cats: evidence for RD-114 being an FcEV(Gag-Pol)/baboon endogenous virus BaEV(Env) recombinant. Journal of Virology. 73: 7994-8002. PMID 10482547 DOI: 10.1128/Jvi.73.10.7994-8002.1999 |
0.304 |
|
| 1999 |
Prins JM, Sol CJ, Renwick N, Goudsmit J, Veenstra J, Reiss P. Favourable effect of chemotherapy on clinical symptoms and human herpesvirus-8 DNA load in a patient with Kaposi's sarcoma presenting with fever and anemia. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 18: 499-502. PMID 10482028 DOI: 10.1007/S100960050331 |
0.402 |
|
| 1999 |
Notermans DW, Pakker NG, Hamann D, Foudraine NA, Kauffmann RH, Meenhorst PL, Goudsmit J, Roos MT, Schellekens PT, Miedema F, Danner SA. Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults. The Journal of Infectious Diseases. 180: 1050-6. PMID 10479130 DOI: 10.1086/315013 |
0.409 |
|
| 1999 |
Abebe A, Demissie D, Goudsmit J, Brouwer M, Kuiken CL, Pollakis G, Schuitemaker H, Fontanet AL, Rinke de Wit TF. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. Aids (London, England). 13: 1305-11. PMID 10449282 DOI: 10.1097/00002030-199907300-00006 |
0.474 |
|
| 1999 |
Pontesilli O, Carotenuto P, Kerkhof-Garde SR, Roos MT, Keet IP, Coutinho RA, Goudsmit J, Miedema F. Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection. Aids Research and Human Retroviruses. 15: 973-81. PMID 10445809 DOI: 10.1089/088922299310485 |
0.477 |
|
| 1999 |
Goudsmit J, Lukashov VV. Dating the origin of HIV-1 subtypes. Nature. 400: 325-6. PMID 10432109 DOI: 10.1038/22454 |
0.468 |
|
| 1999 |
Mang R, Goudsmit J, van der Kuyl AC. Novel endogenous type C retrovirus in baboons: complete sequence, providing evidence for baboon endogenous virus gag-pol ancestry. Journal of Virology. 73: 7021-6. PMID 10400802 DOI: 10.1128/Jvi.73.8.7021-7026.1999 |
0.309 |
|
| 1999 |
de Baar MP, van der Schoot AM, Goudsmit J, Jacobs F, Ehren R, van der Horn KH, Oudshoorn P, de Wolf F, de Ronde A. Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target. Journal of Clinical Microbiology. 37: 1813-8. PMID 10325329 DOI: 10.1128/Jcm.37.6.1813-1818.1999 |
0.467 |
|
| 1999 |
de Jong JJ, Goudsmit J, Lukashov VV, Hillebrand ME, Baan E, Huismans R, Danner SA, ten Veen JH, de Wolf F, Jurriaans S. Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs. Aids (London, England). 13: 75-80. PMID 10207547 DOI: 10.1097/00002030-199901140-00010 |
0.43 |
|
| 1999 |
de Baar MP, van der Horn KH, Goudsmit J, de Ronde A, de Wolf F. Detection of human immunodeficiency virus type 1 nucleocapsid protein p7 in vitro and in vivo. Journal of Clinical Microbiology. 37: 63-7. PMID 9854065 DOI: 10.1128/Jcm.37.1.63-67.1999 |
0.409 |
|
| 1998 |
Bogers WM, Koornstra WH, Dubbes RH, ten Haaft PJ, Verstrepen BE, Jhagjhoorsingh SS, Haaksma AG, Niphuis H, Laman JD, Norley S, Schuitemaker H, Goudsmit J, Hunsmann G, Heeney JL, Wigzell H. Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees. The Journal of General Virology. 79: 2895-903. PMID 9880002 DOI: 10.1099/0022-1317-79-12-2895 |
0.466 |
|
| 1998 |
Renwick N, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, Lange JM, Schulz TF, Goudsmit J. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. Aids (London, England). 12: 2481-8. PMID 9875587 DOI: 10.1097/00002030-199818000-00018 |
0.486 |
|
| 1998 |
Goudsmit J, Lukashov VV, van Ameijden EJ, Zorgdrager F, van den Burg R, Cornelissen M. Impact of sexual versus parenteral transmission events on the evolution of the gag and env genes of HIV type 1. Aids Research and Human Retroviruses. 14: 1483-6. PMID 9824326 DOI: 10.1089/Aid.1998.14.1483 |
0.4 |
|
| 1998 |
van Rij RP, de Roda Husman AM, Brouwer M, Goudsmit J, Coutinho RA, Schuitemaker H. Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants. The Journal of Infectious Diseases. 178: 1806-11. PMID 9815240 DOI: 10.1086/314522 |
0.461 |
|
| 1998 |
van der Hoek L, Goudsmit J, Maas J, Sol CJ. Human immunodeficiency virus type 1 in faeces and serum: evidence against independently evolving subpopulations. The Journal of General Virology. 79: 2455-9. PMID 9780051 DOI: 10.1099/0022-1317-79-10-2455 |
0.451 |
|
| 1998 |
Lukashov VV, Karamov EV, Eremin VF, Titov LP, Goudsmit J. Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus. Aids Research and Human Retroviruses. 14: 1299-303. PMID 9764916 DOI: 10.1089/Aid.1998.14.1299 |
0.397 |
|
| 1998 |
Carotenuto P, Looij D, Keldermans L, de Wolf F, Goudsmit J. Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection. Aids (London, England). 12: 1591-600. PMID 9764777 DOI: 10.1097/00002030-199813000-00005 |
0.425 |
|
| 1998 |
Beld M, Penning M, van Putten M, van den Hoek A, Lukashov V, McMorrow M, Goudsmit J. Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies. Journal of Clinical Microbiology. 36: 3002-6. PMID 9738057 DOI: 10.1128/Jcm.36.10.3002-3006.1998 |
0.363 |
|
| 1998 |
Notermans DW, Goudsmit J, Danner SA, de Wolf F, Perelson AS, Mittler J. Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen. Aids (London, England). 12: 1483-90. PMID 9727569 DOI: 10.1097/00002030-199812000-00010 |
0.42 |
|
| 1998 |
Nkengasong JN, Willems B, Janssens W, Cheingsong-Popov R, Heyndrickx L, Barin F, Ondoa P, Fransen K, Goudsmit J, van der Groen G. Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing. Aids (London, England). 12: 1405-12. PMID 9727560 DOI: 10.1097/00002030-199812000-00001 |
0.323 |
|
| 1998 |
Goudsmit J, Lukashov V, de Jong J, de Ronde T. New HIV variants: subtypes, virulence variants and drug resistant mutants. The Netherlands Journal of Medicine. 52: 261-4. PMID 9718926 DOI: 10.1016/S0300-2977(98)00041-2 |
0.384 |
|
| 1998 |
Weverling GJ, Lange JM, Jurriaans S, Prins JM, Lukashov VV, Notermans DW, Roos M, Schuitemaker H, Hoetelmans RM, Danner SA, Goudsmit J, de Wolf F. Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy. Aids (London, England). 12: F117-22. PMID 9708401 DOI: 10.1097/00002030-199811000-00003 |
0.382 |
|
| 1998 |
Ondoa P, Willems B, Fransen K, Nkengasong J, Janssens W, Heyndrickx L, Zekeng L, Ndumbe P, Simon F, Saragosti S, Gürtler L, Peeters M, Korber B, Goudsmit J, van der Groen G. Evaluation of different V3 peptides in an enzyme immunoassay for specific HIV type 1 group O antibody detection. Aids Research and Human Retroviruses. 14: 963-72. PMID 9686642 DOI: 10.1089/Aid.1998.14.963 |
0.398 |
|
| 1998 |
Op de Coul EL, Lukashov VV, van Doornum GJ, Goudsmit J, Coutinho RA. Multiple HIV-1 subtypes present amongst heterosexuals in Amsterdam 1988-1996: no evidence for spread of non-B subtypes. Aids (London, England). 12: 1253-5. PMID 9677181 DOI: 10.1097/00002030-199810000-00024 |
0.435 |
|
| 1998 |
Lukashov VV, Goudsmit J. HIV heterogeneity and disease progression in AIDS: a model of continuous virus adaptation. Aids (London, England). 12: S43-52. PMID 9632983 |
0.359 |
|
| 1998 |
de Wolf F, de Jong JJ, Hertogs K, Danner SA, Lange JM, Goudsmit J. [Virological evaluation of treating HIV-infected patients with (combinations of) antiretroviral drugs at the Amsterdam Academic Medical Center, 1996/'97]. Nederlands Tijdschrift Voor Geneeskunde. 142: 573-8. PMID 9623114 |
0.359 |
|
| 1998 |
Beld M, Penning M, Lukashov V, McMorrow M, Roos M, Pakker N, van den Hoek A, Goudsmit J. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology. 244: 504-12. PMID 9601518 DOI: 10.1006/Viro.1998.9130 |
0.407 |
|
| 1998 |
Lukashov VV, Op de Coul EL, Coutinho RA, Goudsmit J. HIV-1 strains specific for Dutch injecting drug users in heterosexually infected individuals in The Netherlands. Aids (London, England). 12: 635-41. PMID 9583604 DOI: 10.1097/00002030-199806000-00013 |
0.447 |
|
| 1998 |
Valli PJ, Goudsmit J. Structured-tree topology and adaptive evolution of the simian immunodeficiency virus SIVsm envelope during serial passage in rhesus macaques according to likelihood mapping and quartet puzzling. Journal of Virology. 72: 3673-83. PMID 9557648 DOI: 10.1128/Jvi.72.5.3673-3683.1998 |
0.476 |
|
| 1998 |
van der Hoek L, Sol CJ, Maas J, Lukashov VV, Kuiken CL, Goudsmit J. Genetic differences between human immunodeficiency virus type 1 subpopulations in faeces and serum. The Journal of General Virology. 79: 259-67. PMID 9472610 DOI: 10.1099/0022-1317-79-2-259 |
0.442 |
|
| 1998 |
Notermans DW, Jurriaans S, de Wolf F, Foudraine NA, de Jong JJ, Cavert W, Schuwirth CM, Kauffmann RH, Meenhorst PL, McDade H, Goodwin C, Leonard JM, Goudsmit J, Danner SA. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group. Aids (London, England). 12: 167-73. PMID 9468365 DOI: 10.1097/00002030-199802000-00006 |
0.439 |
|
| 1998 |
Xiao L, Owen SM, Goldman I, Lal AA, deJong JJ, Goudsmit J, Lal RB. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology. 240: 83-92. PMID 9448692 DOI: 10.1006/Viro.1997.8924 |
0.422 |
|
| 1998 |
Blaak H, van't Wout AB, Brouwer M, Cornelissen M, Kootstra NA, Albrecht-van Lent N, Keet RP, Goudsmit J, Coutinho RA, Schuitemaker H. Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples. Journal of Virology. 72: 218-24. PMID 9420218 DOI: 10.1128/Jvi.72.1.218-224.1998 |
0.501 |
|
| 1998 |
Renwick N, Halaby T, Weverling GJ, Valk M, Hemmelder B, Kempen Iv, Simpson G, Schulz T, Lange J, Goudsmit J. Hhv8 Antibody Seropositivity Is Predictive Of Ks Development In Hiv-1 Infected Individuals. Journal of Acquired Immune Deficiency Syndromes. 17. DOI: 10.1097/00042560-199804010-00071 |
0.605 |
|
| 1997 |
de Wolf F, Spijkerman I, Schellekens PT, Langendam M, Kuiken C, Bakker M, Roos M, Coutinho R, Miedema F, Goudsmit J. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion. Aids (London, England). 11: 1799-806. PMID 9412697 DOI: 10.1097/00002030-199715000-00003 |
0.405 |
|
| 1997 |
de Roda Husman AM, Koot M, Cornelissen M, Keet IP, Brouwer M, Broersen SM, Bakker M, Roos MT, Prins M, de Wolf F, Coutinho RA, Miedema F, Goudsmit J, Schuitemaker H. Association between CCR5 genotype and the clinical course of HIV-1 infection. Annals of Internal Medicine. 127: 882-90. PMID 9382366 DOI: 10.7326/0003-4819-127-10-199711150-00004 |
0.438 |
|
| 1997 |
Blaak H, de Wolf F, van 't Wout AB, Pakker NG, Bakker M, Goudsmit J, Schuitemaker H. Temporal relationship between human immunodeficiency virus type 1 RNA levels in serum and cellular infectious load in peripheral blood. The Journal of Infectious Diseases. 176: 1383-7. PMID 9359744 DOI: 10.1086/517327 |
0.426 |
|
| 1997 |
de Wolf F, Goudsmit J. [AIDS; new developments. III. Predictive value of the quantity of HIV-RNA for the course of the HIV infection and the effect of the treatment]. Nederlands Tijdschrift Voor Geneeskunde. 141: 1043-50. PMID 9340561 |
0.371 |
|
| 1997 |
Spijkerman IJ, Prins M, Goudsmit J, Veugelers PJ, Coutinho RA, Miedema F, de Wolf F. Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men. Aids (London, England). 11: 1383-8. PMID 9302449 DOI: 10.1097/00002030-199711000-00013 |
0.431 |
|
| 1997 |
de Jong MD, de Boer RJ, de Wolf F, Foudraine NA, Boucher CA, Goudsmit J, Lange JM. Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment. Aids (London, England). 11: F79-84. PMID 9302437 DOI: 10.1097/00002030-199711000-00002 |
0.445 |
|
| 1997 |
Simonon A, Mulder-Kampinga GA, van de Perre P, Karita E, Msellati P, Kuiken C, Goudsmit J. Evolution of human immunodeficiency virus subtype A in women seroconverting post partum and in their offspring post-natally infected by ingestion of breast milk. The Journal of General Virology. 78: 2225-33. PMID 9292010 DOI: 10.1099/0022-1317-78-9-2225 |
0.37 |
|
| 1997 |
Frissen PH, de Wolf F, Reiss P, Bakker PJ, Veenhof CH, Danner SA, Goudsmit J, Lange JM. High-dose interferon-alpha2a exerts potent activity against human immunodeficiency virus type 1 not associated with antitumor activity in subjects with Kaposi's sarcoma. The Journal of Infectious Diseases. 176: 811-4. PMID 9291341 DOI: 10.1086/517309 |
0.454 |
|
| 1997 |
Keet IP, Janssen M, Veugelers PJ, Miedema F, Klein MR, Goudsmit J, Coutinho RA, de Wolf F. Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years. The Journal of Infectious Diseases. 176: 665-71. PMID 9291313 DOI: 10.1086/514088 |
0.372 |
|
| 1997 |
Abebe A, Kuiken CL, Goudsmit J, Valk M, Messele T, Sahlu T, Yeneneh H, Fontanet A, De Wolf F, Rinke De Wit TF. HIV type 1 subtype C in Addis Ababa, Ethiopia. Aids Research and Human Retroviruses. 13: 1071-5. PMID 9264295 DOI: 10.1089/Aid.1997.13.1071 |
0.457 |
|
| 1997 |
Cornelissen M, van den Burg R, Zorgdrager F, Lukashov V, Goudsmit J. pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D. Journal of Virology. 71: 6348-58. PMID 9261352 DOI: 10.1128/Jvi.71.9.6348-6358.1997 |
0.381 |
|
| 1997 |
Lukashov VV, Goudsmit J. Evolution of the human immunodeficiency virus type 1 subtype-specific V3 domain is confined to a sequence space with a fixed distance to the subtype consensus. Journal of Virology. 71: 6332-8. PMID 9261350 DOI: 10.1128/Jvi.71.9.6332-6338.1997 |
0.473 |
|
| 1997 |
Tsai WP, Rimelzwaan GF, Merges MJ, Wu SC, Conley S, Kung HF, Garrity R, Goudsmit J, Nara PL. Preliminary findings of an in vitro human spleen mononuclear cell culture system for primary isolates of HIV type 1. Aids Research and Human Retroviruses. 13: 967-77. PMID 9223413 DOI: 10.1089/Aid.1997.13.967 |
0.473 |
|
| 1997 |
Goudsmit J, de Ronde A, de Rooij E, de Boer R. Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215. Journal of Virology. 71: 4479-84. PMID 9151839 DOI: 10.1128/Jvi.71.6.4479-4484.1997 |
0.441 |
|
| 1997 |
Cavert W, Notermans DW, Staskus K, Wietgrefe SW, Zupancic M, Gebhard K, Henry K, Zhang ZQ, Mills R, McDade H, Schuwirth CM, Goudsmit J, Danner SA, Haase AT. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science (New York, N.Y.). 276: 960-4. PMID 9139661 DOI: 10.1126/Science.276.5314.960 |
0.482 |
|
| 1997 |
Cornelissen M, Kuiken C, Zorgdrager F, Hartman S, Goudsmit J. Gross defects in the vpr and vpu genes of HIV type 1 cannot explain the differences in RNA copy number between long-term asymptomatics and progressors. Aids Research and Human Retroviruses. 13: 247-52. PMID 9115812 DOI: 10.1089/Aid.1997.13.247 |
0.424 |
|
| 1997 |
van der Kuyl AC, Mang R, Dekker JT, Goudsmit J. Complete nucleotide sequence of simian endogenous type D retrovirus with intact genome organization: evidence for ancestry to simian retrovirus and baboon endogenous virus. Journal of Virology. 71: 3666-76. PMID 9094640 DOI: 10.1128/Jvi.71.5.3666-3676.1997 |
0.308 |
|
| 1997 |
Lukashov VV, Goudsmit J. Founder virus population related to route of virus transmission: a determinant of intrahost human immunodeficiency virus type 1 evolution? Journal of Virology. 71: 2023-30. PMID 9032334 DOI: 10.1128/Jvi.71.3.2023-2030.1997 |
0.505 |
|
| 1997 |
Heeney JL, Bruck C, Goudsmit J, Montagnier L, Schultz A, Tyrrell D, Zolla-Pazner S. Immune correlates of protection from HIV infection and AIDS. Immunology Today. 18: 4-8. PMID 9018965 DOI: 10.1016/S0167-5699(97)80005-9 |
0.455 |
|
| 1997 |
Signoret N, de Jong J, Goudsmit J, Sattentau QJ. Mutations within the CD4-CDR-3-like loop allow replication in an immortalized T cell line of HIV type 1 viruses chimeric for envelope glycoproteins containing non-syncytium-inducing V3 loops. Aids Research and Human Retroviruses. 13: 121-3. PMID 9007197 DOI: 10.1089/Aid.1997.13.121 |
0.416 |
|
| 1997 |
Kampinga GA, Simonon A, Van de Perre P, Karita E, Msellati P, Goudsmit J. Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. Virology. 227: 63-76. PMID 9007059 DOI: 10.1006/Viro.1996.8318 |
0.379 |
|
| 1997 |
Husman AMdR, Comelissen MTE, Koot M, Keet IPM, Brouwer M, Broersen S, Bakker M, Roos MTL, Haastrecht Hv, Wolf Fd, Klein MR, Coutinho R, Miedema F, Goudsmit J, Schuitemaker H. CCR5 Δ32 heterozygosity is an early independent progression marker for AIDS in human immunodeficiency virus type 1 infected subjects Immunology Letters. 56: 15. DOI: 10.1016/S0165-2478(97)85059-6 |
0.394 |
|
| 1996 |
Portegies P, Danner SA, Enting RH, Meilof J, de Wolf F, Goudsmit J. Decline of HIV-1 RNA in cerebrospinal fluid during zidovudine treatment. Antiviral Therapy. 1: 195. PMID 11322255 |
0.624 |
|
| 1996 |
van der Kuyl AC, Dekker JT, Goudsmit J. Baboon endogenous virus evolution and ecology. Trends in Microbiology. 4: 455-9. PMID 8950816 DOI: 10.1016/0966-842X(96)10064-0 |
0.455 |
|
| 1996 |
Keet IP, Veugelers PJ, Koot M, de Weerd MH, Roos MT, Miedema F, de Wolf F, Goudsmit J, Coutinho RA. Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993. Aids (London, England). 10: 1601-2. PMID 8931802 DOI: 10.1097/00002030-199611000-00025 |
0.461 |
|
| 1996 |
Wolthers KC, Bea G, Wisman A, Otto SA, de Roda Husman AM, Schaft N, de Wolf F, Goudsmit J, Coutinho RA, van der Zee AG, Meyaard L, Miedema F. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science (New York, N.Y.). 274: 1543-7. PMID 8929418 DOI: 10.1016/S0165-2478(97)85092-4 |
0.414 |
|
| 1996 |
Kuiken CL, Lukashov VV, Baan E, Dekker J, Leunissen JA, Goudsmit J. Evidence for limited within-person evolution of the V3 domain of the HIV-1 envelope in the amsterdam population. Aids (London, England). 10: 31-7. PMID 8924249 DOI: 10.1097/00002030-199601000-00005 |
0.364 |
|
| 1996 |
De Jong J, Simon F, Van der Groen G, Baan E, Saragosti S, Brun-Vézinet F, Goudsmit J. V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells. Aids Research and Human Retroviruses. 12: 1503-7. PMID 8911575 DOI: 10.1089/Aid.1996.12.1503 |
0.469 |
|
| 1996 |
Cornelissen M, Kampinga G, Zorgdrager F, Goudsmit J. Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization. Journal of Virology. 70: 8209-12. PMID 8892955 DOI: 10.1128/Jvi.70.11.8209-8212.1996 |
0.354 |
|
| 1996 |
van der Hoek L, Sol CJ, Snijders F, Bartelsman JF, Boom R, Goudsmit J. Human immunodeficiency virus type 1 RNA populations in faeces with higher homology to intestinal populations than to blood populations. The Journal of General Virology. 77: 2415-25. PMID 8887472 DOI: 10.1099/0022-1317-77-10-2415 |
0.427 |
|
| 1996 |
Lukashov VV, Kuiken CL, Vlahov D, Coutinho RA, Goudsmit J. Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe. Aids Research and Human Retroviruses. 12: 1179-83. PMID 8844022 DOI: 10.1089/Aid.1996.12.1179 |
0.367 |
|
| 1996 |
de Ronde A, Schuurman R, Goudsmit J, van den Hoek A, Boucher C. First case of new infection with zidovudine-resistant HIV-1 among prospectively studied intravenous drug users and homosexual men in Amsterdam, The Netherlands. Aids (London, England). 10: 231-2. PMID 8838715 DOI: 10.1097/00002030-199602000-00017 |
0.402 |
|
| 1996 |
Jurriaans S, Goudsmit J. Fluctuations in steady state level of genomic HIV-1 RNA and replication intermediates related to disease progression rate. Immunology Letters. 51: 15-22. PMID 8811339 DOI: 10.1016/0165-2478(96)02549-7 |
0.441 |
|
| 1996 |
Lukashov VV, Kuiken CL, Boer K, Goudsmit J. HIV type 1 subtypes in The Netherlands circulating among women originating from AIDS-endemic regions. Aids Research and Human Retroviruses. 12: 951-3. PMID 8798980 DOI: 10.1089/Aid.1996.12.951 |
0.423 |
|
| 1996 |
Goudsmit J, De Ronde A, Ho DD, Perelson AS. Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase. Journal of Virology. 70: 5662-4. PMID 8764084 DOI: 10.1128/Jvi.70.8.5662-5664.1996 |
0.313 |
|
| 1996 |
Kuiken CL, Lukashov VV, Boer K, Goudsmit J. [Introduction of exotic HIV-1 variants in The Netherlands]. Nederlands Tijdschrift Voor Geneeskunde. 140: 1033-5. PMID 8684497 |
0.354 |
|
| 1996 |
Kuiken CL, Cornelissen MT, Zorgdrager F, Hartman S, Gibbs AJ, Goudsmit J. Consistent risk group-associated differences in human immunodeficiency virus type 1 vpr, vpu and V3 sequences despite independent evolution. The Journal of General Virology. 77: 783-92. PMID 8627267 DOI: 10.1099/0022-1317-77-4-783 |
0.313 |
|
| 1995 |
Haaft Pt, Cornelissen M, Goudsmit J, Koornstra W, Dubbes R, Niphuis H, Peeters M, Thiriart C, Bruck C, Heeney JL. Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination Journal of General Virology. 76: 1015-1020. PMID 9049351 DOI: 10.1099/0022-1317-76-4-1015 |
0.477 |
|
| 1995 |
Lukashov VV, Goudsmit J. Increasing genotypic and phenotypic selection from the original genomic RNA populations of HIV-1 strains LAI and MN (NM) by peripheral blood mononuclear cell culture, B-cell-line propagation and T-cell-line adaptation. Aids (London, England). 9: 1307-11. PMID 8605049 DOI: 10.1097/00002030-199512000-00002 |
0.399 |
|
| 1995 |
Cornelissen M, Hogervorst E, Zorgdrager F, Hartman S, Goudsmit J. Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites. Aids Research and Human Retroviruses. 11: 1169-75. PMID 8573372 DOI: 10.1089/Aid.1995.11.1169 |
0.408 |
|
| 1995 |
Langedijk JP, Zwart G, Goudsmit J, Meloen RH. Fine specificity of antibody recognition may predict amino acid substitution in the third variable region of gp120 during HIV type 1 infection. Aids Research and Human Retroviruses. 11: 1153-62. PMID 8573370 DOI: 10.1089/Aid.1995.11.1153 |
0.44 |
|
| 1995 |
Veenstra J, Schuurman R, Cornelissen M, van't Wout AB, Boucher CA, Schuitemaker H, Goudsmit J, Coutinho RA. Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 21: 556-60. PMID 8527543 DOI: 10.1093/Clinids/21.3.556 |
0.425 |
|
| 1995 |
De Wolf F, Hogervorst E, Goudsmit J, Fenyö EM, Rübsamen-Waigmann H, Holmes H, Galvao-Castro B, Karita E, Wasi C, Sempala SD. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. Aids Research and Human Retroviruses. 10: 1387-400. PMID 7888192 DOI: 10.1089/Aid.1994.10.1387 |
0.42 |
|
| 1995 |
Mulder-Kampinga GA, Simonon A, Kuiken CL, Dekker J, Scherpbier HJ, Perre Pvd, Boer K, Goudsmit J. Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child. Journal of Virology. 69: 2285-2296. PMID 7884875 DOI: 10.1128/Jvi.69.4.2285-2296.1995 |
0.319 |
|
| 1995 |
Kuiken CL, Goudsmit J, Weiller GF, Armstrong JS, Hartman S, Portegies P, Dekker J, Cornelissen M. Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex. The Journal of General Virology. 76: 175-80. PMID 7844529 DOI: 10.1099/0022-1317-76-1-175 |
0.612 |
|
| 1995 |
Copeland KF, Hendrikx PJ, Haaksma AG, Fiering S, Van Lier R, Goudsmit J, Heeney JL. Comparison of the response to T-cell activation by integrated HIV-1 and HTLV-1 LTR-lacZ vectors. Virology. 209: 633-6. PMID 7778294 DOI: 10.1006/Viro.1995.1295 |
0.414 |
|
| 1995 |
Hoek LVD, Boom R, Goudsmit J, Snijders F, Sol CJA. Isolation of human immunodeficiency virus type 1 (HIV-1) RNA from feces by a simple method and difference between HIV-1 subpopulations in feces and serum. Journal of Clinical Microbiology. 33: 581-588. PMID 7751361 DOI: 10.1128/Jcm.33.3.581-588.1995 |
0.485 |
|
| 1995 |
Jurriaans S, de Ronde A, Dekker J, Cornelissen M, Goudsmit J. Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo. Journal of Medical Virology. 45: 91-8. PMID 7714497 DOI: 10.1002/Jmv.1890450117 |
0.462 |
|
| 1995 |
Hogervorst E, Jurriaans S, Wolf Fd, Wijk Av, Wiersma A, Valk M, Roos M, Gemen Bv, Coutinho R, Miedema F, Goudsmit J. Predictors for Non- and Slow Progression in Human Immunodeficiency Virus (HIV) Type 1 Infection: Low Viral RNA Copy Numbers in Serum and Maintenance of High HIV-1 p24-Specific but Not V3-Specific Antibody Levels The Journal of Infectious Diseases. 171: 811-821. PMID 7706807 DOI: 10.1093/Infdis/171.4.811 |
0.468 |
|
| 1995 |
Hogervorst E, de Jong J, van Wijk A, Bakker M, Valk M, Nara P, Goudsmit J. Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies. Journal of Virology. 69: 6342-51. PMID 7666535 DOI: 10.1128/Jvi.69.10.6342-6351.1995 |
0.385 |
|
| 1995 |
Jurriaans S, Weverling GJ, Goudsmit J, Boogaard J, Brok M, Strijp DV, Lange J, Koot M, Gemen BV. Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS Aids Research and Human Retroviruses. 11: 473-479. PMID 7632462 DOI: 10.1089/Aid.1995.11.473 |
0.428 |
|
| 1995 |
Schuurman H-, Joling P, Wichen DFv, Rademakers LHPM, Broekhuizen R, Weger RAd, Tweel JGvd, Goudsmit J. Follicular Dendritic Cells and Infection by Human Immunodeficiency Virus Type 1—A Crucial Target Cell and Virus Reservoir Current Topics in Microbiology and Immunology. 201: 161-188. PMID 7587350 DOI: 10.1007/978-3-642-79603-6_10 |
0.337 |
|
| 1995 |
Lukashov VV, Kuiken CL, Goudsmit J. Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. Journal of Virology. 69: 6911-6. PMID 7474108 DOI: 10.1128/Jvi.69.11.6911-6916.1995 |
0.376 |
|
| 1995 |
Goudsmit J. The role of viral diversity in HIV pathogenesis. Journal of Acquired Immune Deficiency Syndromes. 10. DOI: 10.1097/00042560-199510001-00004 |
0.428 |
|
| 1995 |
Lukashov VV, Cornelissen MT, Goudsmit J, Papuashvilli MN, Rytik PG, Khaitov RM, Karamov EV, Wolf Fd. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania Aids. 9: 435-439. DOI: 10.1097/00002030-199505000-00004 |
0.496 |
|
| 1994 |
Back NKT, Smit L, Jong JD, Keulen W, Schutten M, Goudsmit J, Tersmette M. An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. Virology. 199: 431-438. PMID 8122371 DOI: 10.1006/Viro.1994.1141 |
0.449 |
|
| 1994 |
Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays Journal of Virology. 68: 6672-6683. PMID 8084001 DOI: 10.1128/Jvi.68.10.6672-6683.1994 |
0.384 |
|
| 1994 |
Zwart G, Back NKT, Ramautarsing C, Valk M, Hoek Lvd, Goudsmit J. Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domain. Aids Research and Human Retroviruses. 10: 245-251. PMID 8018385 DOI: 10.1089/Aid.1994.10.245 |
0.499 |
|
| 1994 |
Jurriaans S, Gemen BV, Weverling GJ, Strup DV, Nara P, Coutinho R, Koot M, Schuitemaker H, Goudsmit J. The Natural History of HIV-1 Infection: Virus Load and Virus Phenotype Independent Determinants of Clinical Course? Virology. 204: 223-233. PMID 7916514 DOI: 10.1006/Viro.1994.1526 |
0.475 |
|
| 1994 |
Portegies P, Enting RH, de Jong MD, Danner SA, Reiss P, Goudsmit J, Lange JM. AIDS dementia complex and didanosine. Lancet. 344: 759. PMID 7915809 DOI: 10.1016/S0140-6736(94)92252-7 |
0.577 |
|
| 1994 |
Keet IP, Krol A, Klein MR, Veugelers P, de Wit J, Roos M, Koot M, Goudsmit J, Miedema F, Coutinho RA. Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts. The Journal of Infectious Diseases. 169: 1236-43. PMID 7910835 DOI: 10.1093/Infdis/169.6.1236 |
0.454 |
|
| 1994 |
Shpaer EG, Delwart EL, Kuiken CL, Goudsmit J, Bachmann MH, Mullins JI. Conserved V3 loop sequences and transmission of human immunodeficiency virus type 1 Aids Research and Human Retroviruses. 10: 1679-1684. PMID 7888227 DOI: 10.1089/Aid.1994.10.1679 |
0.476 |
|
| 1994 |
Zwart G, van der Hoek L, Valk M, Cornelissen MT, Baan E, Dekker J, Koot M, Kuiken CL, Goudsmit J. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression. Virology. 201: 285-93. PMID 7514319 DOI: 10.1006/Viro.1994.1293 |
0.45 |
|
| 1993 |
Zwart G, Wolfs TF, Bookelman R, Hartman S, Bakker M, Boucher CA, Kuiken C, Goudsmit J. Greater diversity of the HIV-1 V3 neutralization domain in Tanzania compared with The Netherlands: serological and genetic analysis. Aids (London, England). 7: 467-74. PMID 8507412 DOI: 10.1097/00002030-199304000-00003 |
0.419 |
|
| 1993 |
Lange JMA, Teeuwsen VJP, Boucher CAB, Vahlne A, Barin F, Tjong-A-Hung S, Dekker J, Parkhede U, Wolf FD, Goudsmit J. Antigenic variation of the dominant gp41 epitope in Africa. Aids. 7: 461-466. PMID 8507411 DOI: 10.1097/00002030-199304000-00002 |
0.488 |
|
| 1993 |
Kuiken CL, Zwart G, Baan E, Coutinho RA, Hoek JARVD, Goudsmit J. Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic Proceedings of the National Academy of Sciences of the United States of America. 90: 9061-9065. PMID 8415653 DOI: 10.1073/Pnas.90.19.9061 |
0.42 |
|
| 1993 |
Back NKT, Smit L, Schutten M, Nara PL, Tersmette M, Goudsmit J. Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies. Journal of Virology. 67: 6897-6902. PMID 8411395 DOI: 10.1128/Jvi.67.11.6897-6902.1993 |
0.448 |
|
| 1993 |
Joling P, Bakker LJ, Wichen DFv, Graaf Ld, Meerloo T, Visser MR, Strijp JAGv, Goudsmit J, Verhoef J, Schuurman H. Binding of HIV-1 to human follicular dendritic cells. Advances in Experimental Medicine and Biology. 329: 455-460. PMID 8379409 DOI: 10.1007/978-1-4615-2930-9_76 |
0.499 |
|
| 1993 |
Joling P, Biberfeld P, Parmentier HK, Wichen DFv, Meerloo T, Rademakers LHPM, Tschopp J, Goudsmit J, Schuurman H. Lymphoid follicles in cynomolgus monkeys after infection with simian immunodeficiency virus. Advances in Experimental Medicine and Biology. 329: 405-409. PMID 8379403 DOI: 10.1007/978-1-4615-2930-9_68 |
0.482 |
|
| 1993 |
Mulder-Kampinga GA, Kuiken C, Dekker J, Scherpbier HJ, Boer K, Goudsmit J. Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intra-uterine virus transmission. The Journal of General Virology. 1747-56. PMID 8376956 DOI: 10.1099/0022-1317-74-9-1747 |
0.327 |
|
| 1993 |
Portegies P, Enting RH, de Gans J, Algra PR, Derix MM, Lange JM, Goudsmit J. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. Aids (London, England). 7: 669-75. PMID 8318174 DOI: 10.1097/00002030-199305000-00010 |
0.659 |
|
| 1993 |
Portegies P, Godfried MH, Hintzen RQ, Stam J, van der Poll T, Bakker M, van Deventer SJ, van Lier RA, Goudsmit J. Low levels of specific T cell activation marker CD27 accompanied by elevated levels of markers for non-specific immune activation in the cerebrospinal fluid of patients with AIDS dementia complex. Journal of Neuroimmunology. 48: 241-7. PMID 8227320 DOI: 10.1016/0165-5728(93)90198-8 |
0.645 |
|
| 1993 |
Gemen BV, Kievits T, Nara P, Huisman HG, Jurriaans S, Goudsmit J, Lens P. Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification. Aids. 7. PMID 8161439 DOI: 10.1097/00002030-199311002-00020 |
0.368 |
|
| 1993 |
Keet IPM, Krijnen P, Koot M, Lange JMA, Miedema F, Goudsmit J, Coutinho RA. Predictors of Rapid Progression to AIDS in HIV-1 Seroconverters Aids. 7: 51-57. PMID 8095146 DOI: 10.1097/00002030-199301000-00008 |
0.493 |
|
| 1993 |
Meerloo T, Sheikh MA, Bloem AC, de Ronde A, Schutten M, van Els CA, Roholl PJ, Joling P, Goudsmit J, Schuurman HJ. Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study. The Journal of General Virology. 129-35. PMID 8093711 DOI: 10.1099/0022-1317-74-1-129 |
0.407 |
|
| 1993 |
Schutten M, McKnight A, Huisman RC, Thali M, McKeating JA, Sodroski J, Goudsmit J, Osterhaus AD. Further characterization of an antigenic site of HIV-1 gp120 recognized by virus neutralizing human monoclonal antibodies. Aids (London, England). 7: 919-23. PMID 7689324 DOI: 10.1097/00002030-199307000-00003 |
0.511 |
|
| 1993 |
Zwart G, Wolfs TF, Valk M, Van der Hoek L, Kuiken CL, Goudsmit J. Characterization of the specificity of the human antibody response to the V3 neutralization domain of HIV-1. Aids Research and Human Retroviruses. 8: 1897-908. PMID 1489578 DOI: 10.1089/Aid.1992.8.1897 |
0.479 |
|
| 1993 |
Tsai WP, Kung HF, Goudsmit J, Rimmelzwaan G, Minassian A, Garrity R, Nara P. HIV-1 tropism: truth or consequences? Aids Research and Human Retroviruses. 8: 1749-50. PMID 1457187 DOI: 10.1089/Aid.1992.8.1749 |
0.463 |
|
| 1993 |
Wolfs TFW, Nara PL, Goudsmit J. Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination. Chemical Immunology. 56: 1-33. DOI: 10.1159/000421945 |
0.417 |
|
| 1993 |
Mientjes GHC, Ameijden EJCV, Hoek AJARVD, Goudsmit J, Miedema F, Coutinho RA. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment. Aids. 7: 1363-1370. DOI: 10.1097/00002030-199310000-00010 |
0.408 |
|
| 1992 |
Jong JJd, Goudsmit J, Keulen W, Klaver B, Krone W, Tersmette M, Ronde Ad. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. Journal of Virology. 66: 757-765. PMID 1731110 DOI: 10.1128/Jvi.66.2.757-765.1992 |
0.445 |
|
| 1992 |
Jurriaans S, Ronde Ad, Dekker J, Goudsmit J, Cornelissen M. Analysis of human immunodeficiency virus type 1 LTR-LTR junctions in peripheral blood mononuclear cells of infected individuals. Journal of General Virology. 73: 1537-1541. PMID 1607872 DOI: 10.1099/0022-1317-73-6-1537 |
0.449 |
|
| 1992 |
Kuiken CL, Jong JJd, Baan E, Keulen W, Tersmette M, Goudsmit J. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. Journal of Virology. 66: 4622-4627. PMID 1602564 DOI: 10.1128/Jvi.66.7.4622-4627.1992 |
0.339 |
|
| 1992 |
Ronde Ad, Klaver B, Keulen W, Smit L, Goudsmit J. Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes. Virology. 188: 391-395. PMID 1566581 DOI: 10.1016/0042-6822(92)90772-H |
0.486 |
|
| 1992 |
Blumberg B, Epstein L, Ronde Ad, Goudsmit J. HIV1 3′ ORF is open in pathological tissue and accelerates viral replication in primary lymphocytes Research in Virology. 143: 63-65. PMID 1565861 DOI: 10.1016/S0923-2516(06)80083-X |
0.452 |
|
| 1992 |
Bruisten SM, Koppelman MHGM, Dekker JT, Bakker M, Goede REYD, Roos MTL, Wolf FD, Coutinho RA, Goudsmit J, Huisman HG. Concordance of Human Immunodeficiency Virus Detection by Polymerase Chain Reaction and by Serologic Assays in a Dutch Cohort of Seronegative Homosexual Men The Journal of Infectious Diseases. 166: 620-622. PMID 1500745 DOI: 10.1093/Infdis/166.3.620 |
0.514 |
|
| 1992 |
Goudsmit J, Zwart G, Wolfs T. Assessment of HIV-1 Antigenic Diversification Using Serum as Sample Source Aids Research and Human Retroviruses. 8: 1473-1473. PMID 1466985 DOI: 10.1089/Aid.1992.8.1473 |
0.441 |
|
| 1992 |
Meerloo T, Parmentier HK, Osterhaus ADME, Goudsmit J, Schuurman H. Modulation of cell surface molecules during HIV-1 infection of H9 cells. An immunoelectron microscopic study. Aids. 6: 1105-1116. PMID 1466841 DOI: 10.1097/00002030-199210000-00007 |
0.377 |
|
| 1992 |
Koken SEC, Wamel JLBV, Goudsmit J, Berkhout B, Geelent JLMC. Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology. 191: 968-972. PMID 1448931 DOI: 10.1016/0042-6822(92)90274-S |
0.428 |
|
| 1992 |
McKnight A, Clapham PR, Goudsmit J, Cheingsong-Popov R, Weber JN, Weiss RA. Development of HIV-1 group-specific neutralizing antibodies after seroconversion Aids. 6: 799-802. PMID 1418776 DOI: 10.1097/00002030-199208000-00005 |
0.475 |
|
| 1992 |
Jong JJD, Ronde AD, Keulen W, Tersmette M, Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. Journal of Virology. 66: 6777-6780. PMID 1404617 DOI: 10.1128/Jvi.66.11.6777-6780.1992 |
0.314 |
|
| 1992 |
Langedijk JPM, Back NKT, Kinney-Thomas E, Bruck C, Francotte M, Goudsmit J, Meloen RH. Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1. Archives of Virology. 126: 129-146. PMID 1381908 DOI: 10.1007/Bf01309690 |
0.416 |
|
| 1992 |
Wolfs TFW, Zwart G, Bakker M, Goudsmit J. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology. 189: 103-110. PMID 1376536 DOI: 10.1016/0042-6822(92)90685-I |
0.372 |
|
| 1992 |
Goudsmit J. Humoral immune responses in human HIV-1 infection clearance of initial burst of virus replication and protection against disease progression. International Reviews of Immunology. 8: 65-81. PMID 1374113 DOI: 10.3109/08830189209056642 |
0.461 |
|
| 1992 |
Goudsmit J. Alternative view on AIDS. The Lancet. 339: 1289-1290. PMID 1349680 DOI: 10.1016/0140-6736(92)91610-K |
0.51 |
|
| 1992 |
Mulder JW, Frissen PHJ, Krijnen P, Endert E, Wolf Fd, Goudsmit J, Masterson JG, Lange JMA. Dehydroepiandrosterone as Predictor for Progression to AIDS in Asymptomatic Human Immunodeficiency Virus-Infected Men The Journal of Infectious Diseases. 165: 413-418. PMID 1347053 DOI: 10.1093/Infdis/165.3.413 |
0.476 |
|
| 1992 |
Boucher CAB, Lange JMA, Miedema FF, Weverling GJ, Koot M, Mulder JW, Goudsmit J, Kellam P, Larder BA, Tersmette M. HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment. Aids. 6: 1259-1264. PMID 1282015 DOI: 10.1097/00002030-199211000-00003 |
0.419 |
|
| 1991 |
Goudsmit J, Back NKT, Nara PL. Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development. The Faseb Journal. 5: 2427-2436. PMID 2065891 DOI: 10.1096/Fasebj.5.10.2065891 |
0.406 |
|
| 1991 |
Back NKT, Haigwood NL, Wolf FD, Jongh BMD, Goudsmit J. Antibody Reactivity to Deletion Mutants of the HIV-1 SF2 Envelope Intervirology. 32: 160-172. PMID 2040587 DOI: 10.1159/000150196 |
0.517 |
|
| 1991 |
Zwart G, Langedijk H, Hoek LVD, Jong JD, Wolfs TFW, Ramautarsing C, Bakker M, Ronde AD, Goudsmit J. Immunodominance and antigenic variation of the principal neutralization domain of HIV-1. Virology. 181: 481-489. PMID 2014634 DOI: 10.1016/0042-6822(91)90880-K |
0.496 |
|
| 1991 |
Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clement M, Goudsmit J. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. Virology. 180: 583-90. PMID 1989385 DOI: 10.1016/0042-6822(91)90072-J |
0.308 |
|
| 1991 |
McRAE B, Lange JAM, Ascher MS, Wolf FD, Sheppard HW, Goudsmit J, Allain J. Immune response to HIV p24 core protein during the early phases of human immunodeficiency virus infection. Aids Research and Human Retroviruses. 7: 637-643. PMID 1931233 DOI: 10.1089/Aid.1991.7.637 |
0.488 |
|
| 1991 |
Teeuwsen VJP, Schalken JJ, Groen Gvd, Akker Rvd, Goudsmit J, Osterhaus ADME. An inhibition enzyme immunoassay using a human monoclonal antibody (K14) reactive with gp41 of HIV-1 for the serology of HIV-1 infections. Aids. 5: 893-896. PMID 1892597 DOI: 10.1097/00002030-199107000-00017 |
0.495 |
|
| 1991 |
Van den Hoek JAR, Al EJM, Huisman JG, Goudsmit J, Coutinho RA. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands Journal of Medical Virology. 34: 100-103. PMID 1890409 DOI: 10.1002/Jmv.1890340206 |
0.394 |
|
| 1991 |
Portegies P, Goudsmit J. [Human T-cell lymphotropic virus Type I (HTLV-I) as a cause of progressive myelopathy]. Nederlands Tijdschrift Voor Geneeskunde. 135: 1302-6. PMID 1865933 |
0.583 |
|
| 1991 |
Holley LH, Goudsmit J, Karplus M. Prediction of optimal peptide mixtures to induce broadly neutralizing antibodies to human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences of the United States of America. 88: 6800-4. PMID 1862103 DOI: 10.1073/Pnas.88.15.6800 |
0.301 |
|
| 1991 |
Teeuwsen VJP, Lange JMA, Keet R, Schattenkerk JKME, Debouck C, Akker RVD, Goudsmit J, Osterhaus ADME. Low number of functionally active B lymphocytes in the peripheral blood of HIV-1-seropositive individuals with low p24-specific serum antibody titers. Aids. 5: 971-979. PMID 1723280 DOI: 10.1097/00002030-199108000-00008 |
0.419 |
|
| 1991 |
Nara PL, Garrity RR, Goudsmit J. Neutralization of HIV-1: a paradox of humoral proportions. The Faseb Journal. 5: 2437-2455. PMID 1712328 DOI: 10.1096/Fasebj.5.10.1712328 |
0.403 |
|
| 1991 |
Wolf FD, Meloen RH, Bakker M, Barin F, Goudsmit J. Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2. Journal of General Virology. 72: 1261-1267. PMID 1710645 DOI: 10.1099/0022-1317-72-6-1261 |
0.468 |
|
| 1991 |
Nowak MA, Anderson RM, McLean AR, Wolfs TF, Goudsmit J, May RM. Antigenic diversity thresholds and the development of AIDS. Science (New York, N.Y.). 254: 963-9. PMID 1683006 DOI: 10.1126/Science.1683006 |
0.423 |
|
| 1991 |
Wolfs TFW, Zwart G, Bakker M, Valk M, Kuiken CL, Goudsmit J. Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution. Virology. 185: 195-205. PMID 1656585 DOI: 10.1016/0042-6822(91)90767-6 |
0.373 |
|
| 1990 |
Nara PL, Smit L, Dunlop N, Hatch W, Merges M, Waters D, Kelliher J, Gallo RC, Fischinger PJ, Goudsmit J. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. Journal of Virology. 64: 3779-91. PMID 2370681 DOI: 10.1128/Jvi.64.8.3779-3791.1990 |
0.513 |
|
| 1990 |
Reiss P, Lange JMA, Ronde AD, Wolf FD, Dekker J, Debouck C, Goudsmit J. Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1. Journal of Medical Virology. 30: 163-168. PMID 2341832 DOI: 10.1002/Jmv.1890300303 |
0.452 |
|
| 1990 |
Lange JM, Boucher CA, Hollak CE, Wiltink EH, Reiss P, van Royen EA, Roos M, Danner SA, Goudsmit J. Failure of zidovudine prophylaxis after accidental exposure to HIV-1. The New England Journal of Medicine. 322: 1375-7. PMID 2325735 DOI: 10.1056/Nejm199005103221907 |
0.434 |
|
| 1990 |
Ujhelyi E, Lange J, Goudsmit J, Salavecz V, Büki B, Füst G, Hollán SR. Correlation of HIV core antigen, antibody and immune complex levels in sera of HIV-infected individuals Aids. 4: 928-929. PMID 2252571 DOI: 10.1097/00002030-199009000-00020 |
0.5 |
|
| 1990 |
Goudsmit J, Geelen J, Keulen W, Notermans D, Kuiken C, Ramautarsing C, Smit L, Koole L, Van Genderen M, Buck H, Sninskyt J, Krone W. Characterization of the African HIV-1 isolate CBL-4 (RUT) by partial sequence analysis and virus neutralization with peptide antibody and antisense phosphate-methylated DNA Aids. 4: 559-564. PMID 2201319 DOI: 10.1097/00002030-199006000-00010 |
0.398 |
|
| 1990 |
Hulsebosch HJ, Claessen FAP, Ginkel CJWv, Kuiters GRR, Goudsmit J, Lange JMA. Human immunodeficiency virus exanthem Journal of the American Academy of Dermatology. 23: 483-486. PMID 2120292 DOI: 10.1016/0190-9622(90)70245-D |
0.528 |
|
| 1990 |
Mulder JW, Krijnen P, Goudsmit J, Schattenkerk JK, Reiss P, Lange JM. HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients. Sexually Transmitted Infections. 66: 138-141. PMID 2115018 DOI: 10.1136/Sti.66.3.138 |
0.355 |
|
| 1990 |
Boucher CAB, Tersmette M, Lange JMA, Kellam P, Goede REYD, Mulder JW, Darby G, Goudsmit J, Larder BA. Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy. The Lancet. 336: 585-590. PMID 1975378 DOI: 10.1016/0140-6736(90)93391-2 |
0.324 |
|
| 1990 |
Griensven GJPV, Vroome EMMD, Wolf FD, Goudsmit J, Roos M, Coutinho RA. Risk Factors For Progression Of Human Immunodeficiency Virus (Hiv) Infection Among Seroconverted And Seropositive Homosexual Men American Journal of Epidemiology. 132: 203-210. PMID 1973594 DOI: 10.1093/Oxfordjournals.Aje.A115649 |
0.491 |
|
| 1990 |
Mulder JW, de Wolf F, Goudsmit J, Cload PA, Coutinho RA, Fiddian AP, Schellekens PT, van der Noordaa J, Lange JM. Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects. Antiviral Research. 13: 127-38. PMID 1972321 DOI: 10.1016/0166-3542(90)90028-6 |
0.728 |
|
| 1990 |
Goudsmit J, Smit L. CD11a/CD 18 (LFA-1) Epitopes Involved in Syncytium Formation Among CD4+ T-Cells Following Cell Free HIV-1 Infection Viral Immunology. 3: 289-293. PMID 1706184 DOI: 10.1089/Vim.1990.3.289 |
0.351 |
|
| 1990 |
Goudsmit J, Meloen RH, Brasseur R. Map of sequential B cell epitopes of the HIV-1 transmembrane protein using human antibodies as probe. Intervirology. 31: 327-338. PMID 1704000 DOI: 10.1159/000150169 |
0.513 |
|
| 1990 |
Wolfs TFW, Jong J-D, Berg HVD, Tijnagel JMGH, Krone WJA, Goudsmit J. Evolution Of Sequences Encoding The Principal Neutralization Epitope Of Human Immunodeficiency Virus 1 Is Host Dependent, Rapid, And Continuous Proceedings of the National Academy of Sciences of the United States of America. 87: 9938-9942. PMID 1702224 DOI: 10.1073/Pnas.87.24.9938 |
0.327 |
|
| 1990 |
Back NKT, Thiriart C, Delers A, Ramautarsing C, Bruck C, Goudsmit J. Association of antibodies blocking HIV-1 gp160-sCD4 attachment with virus neutralizing activity in human sera Journal of Medical Virology. 31: 200-208. PMID 1697332 DOI: 10.1002/Jmv.1890310306 |
0.488 |
|
| 1990 |
Teeuwsen VJP, Siebelink KHJ, Crush-Stanton S, Swerdlow B, Schalken JJ, Goudsmit J, Akker Rvd, Stukart MJ, Uytdehaag FGCM, Osterhaus ADME. Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type I. Aids Research and Human Retroviruses. 6: 381-392. PMID 1692724 DOI: 10.1089/Aid.1990.6.381 |
0.439 |
|
| 1990 |
Boucher CAB, Krone WJA, Goudsmit J, Meloen RH, Naylor PH, Goldstein AL, Sun DK, Sarin PS. Immune response and epitope mapping of a candidate HIV-1 p17 vaccine HGP30 Journal of Clinical Laboratory Analysis. 4: 43-47. PMID 1690277 DOI: 10.1002/Jcla.1860040109 |
0.502 |
|
| 1990 |
Zwart G, de Jong JJ, Wolfs T, van der Hoek L, Smit L, de Ronde A, Tersmette M, Nara P, Goudsmit J. Predominance of HIV-1 serotype distinct from LAV-1/HTLV-IIIB. Lancet (London, England). 335: 474. PMID 1689444 DOI: 10.1016/0140-6736(90)90707-C |
0.479 |
|
| 1990 |
Brake DA, Goudsmit J, Krone WJA, Schammel P, Appleby N, Meloen RH, Debouck C. Characterization of murine monoclonal antibodies to the tat protein from human immunodeficiency virus type 1 Journal of Virology. 64: 962-965. PMID 1688630 DOI: 10.1128/Jvi.64.2.962-965.1990 |
0.336 |
|
| 1990 |
Krone WJA, Sninsky JJ, Goudsmit J. Detection and characterization of HIV-1 by polymerase chain reaction. Journal of Acquired Immune Deficiency Syndromes. 3: 517-524. DOI: 10.1097/00126334-199003050-00008 |
0.4 |
|
| 1990 |
Ancelle-Park RA, Coutinho RA, Brunet J, Piot P, Goudsmit J, Koch MA. Report on a European Community meeting on strategies for development and use of a future HIV vaccine Aids. 4: 1043-1044. DOI: 10.1097/00002030-199010000-00024 |
0.389 |
|
| 1989 |
Portegies P, Epstein LG, Hung ST, de Gans J, Goudsmit J. Human immunodeficiency virus type 1 antigen in cerebrospinal fluid. Correlation with clinical neurologic status. Archives of Neurology. 46: 261-4. PMID 2919978 DOI: 10.1001/Archneur.1989.00520390027010 |
0.712 |
|
| 1989 |
van Griensven GJ, de Vroome EM, Tielman RA, Goudsmit J, de Wolf F, van der Noordaa J, Coutinho RA. Effect of human immunodeficiency virus (HIV) antibody knowledge on high-risk sexual behavior with steady and nonsteady sexual partners among homosexual men. American Journal of Epidemiology. 129: 596-603. PMID 2916553 DOI: 10.1093/Oxfordjournals.Aje.A115172 |
0.645 |
|
| 1989 |
Lelie PN, van der Poel CL, Reesink HW, Huisman HG, Boucher CA, Goudsmit J. Efficacy of the latest generation of antibody assays for (early) detection of HIV 1 and HIV 2 infection. Vox Sanguinis. 56: 59-61. PMID 2916337 DOI: 10.1111/J.1423-0410.1989.Tb03051.X |
0.497 |
|
| 1989 |
Van den Hoek JAR, Van Haastrecht HJA, Scheeringa-Troost B, Goudsmit J, Coutinho RA. HIV infection and STD in drug addicted prostitutes in Amsterdam: Potential for heterosexual HIV transmission Genitourinary Medicine. 65: 146-150. PMID 2788121 DOI: 10.1136/Sti.65.3.146 |
0.475 |
|
| 1989 |
Reiss P, De Ronde A, Lange JMA, De Wolf F, Dekker J, Danner SA, Debouck C, Goudsmit J. Low antigenicity of HIV-1 rev: rev-specific antibody response of limited value as correlate of rev gene expression and disease progression Aids Research and Human Retroviruses. 5: 621-628. PMID 2692659 DOI: 10.1089/Aid.1989.5.621 |
0.478 |
|
| 1989 |
Boucher CAB, De Jager MH, Debouck C, Epstein LG, De Wolf F, Wolfs TFW, Goudsmit J. Antibody response to human immunodeficiency virus type 1 protease according to risk group and disease stage Journal of Clinical Microbiology. 27: 1577-1581. PMID 2671017 DOI: 10.1128/Jcm.27.7.1577-1581.1989 |
0.508 |
|
| 1989 |
Goudsmit J, Dekker JT, Boucher CAB, Smit L, Ronde AD, Debouck C, Barin F. Serum reactivity to HIV-1 accessory gene products distinguishes East African from West African HIV strains as infecting agent. Aids Research and Human Retroviruses. 5: 475-477. PMID 2590553 DOI: 10.1089/Aid.1989.5.475 |
0.508 |
|
| 1989 |
Lange JM, Wolf Fd, Goudsmit J. Markers for progression in HIV infection. Aids. 3. PMID 2575397 DOI: 10.1097/00002030-198901001-00023 |
0.468 |
|
| 1989 |
de Wolf F, Lange JM, Houweling JT, Mulder JW, Beemster J, Schellekens PT, Coutinho RA, van der Noordaa J, Goudsmit J. Appearance of predictors of disease progression in relation to the development of AIDS. Aids (London, England). 3: 563-9. PMID 2571348 DOI: 10.1097/00002030-198909000-00002 |
0.751 |
|
| 1989 |
Wolfs TF, de Wolf F, Breederveld C, Sjamsjoedin-Visser LJ, Roos M, Bakker M, Goudsmit J. Low AIDS attack rate among Dutch haemophiliacs compared to homosexual men: a correlate of HIV antigenaemia frequencies. Vox Sanguinis. 57: 127-32. PMID 2571211 DOI: 10.1111/J.1423-0410.1989.Tb01149.X |
0.492 |
|
| 1989 |
Terpstra FG, Al BJ, Roos MT, De Wolf F, Goudsmit J, Schellekens PT, Miedema F. Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection. European Journal of Immunology. 19: 667-73. PMID 2567244 DOI: 10.1002/Eji.1830190415 |
0.446 |
|
| 1989 |
Tersmette M, Goede REYD, Lange JMA, Wolf FD, Eeftink-Schattenkerk JKM, Schellekens PTA, Coutinho RA, Goudsmit J, Huisman JG, Miedema F. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. The Lancet. 333: 983-985. PMID 2565516 DOI: 10.1016/S0140-6736(89)92628-7 |
0.482 |
|
| 1989 |
Tersmette M, Gruters RA, Wolf FD, Goede REYD, Lange JMA, Schellekens PTA, Goudsmit J, Huisman HG, Miedema F. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. Journal of Virology. 63: 2118-2125. PMID 2564898 DOI: 10.1128/Jvi.63.5.2118-2125.1989 |
0.467 |
|
| 1989 |
Portegies P, de Gans J, Lange JM, Derix MM, Speelman H, Bakker M, Danner SA, Goudsmit J. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. Bmj (Clinical Research Ed.). 299: 819-21. PMID 2510843 DOI: 10.1136/Bmj.299.6703.819 |
0.663 |
|
| 1989 |
Lange J, Vahlne A, Dekker J, Wolf Fd, Goudsmit J. Antibodies to an HIV-1 synthetic peptide with partial homology to MULV P15E do not protect against AIDS Aids. 3: 402-403. PMID 2502156 DOI: 10.1097/00002030-198906000-00013 |
0.443 |
|
| 1989 |
Reiss P, Ronde Ad, Lange JMa, Wolf Fd, Dekker J, Debouck C, Goudsmit J. Antibody response to the viral negative factor (nef) in HIV-1 infection: a correlate of levels of HIV-1 expression. Aids. 3: 227-233. PMID 2500956 DOI: 10.1097/00002030-198904000-00006 |
0.501 |
|
| 1989 |
Griensven GJPV, Vroome EMMD, Goudsmit J, Coutinho RA. Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. Bmj. 298: 218-221. PMID 2493866 DOI: 10.1136/Bmj.298.6668.218 |
0.459 |
|
| 1989 |
Lange JM, de Wolf F, Mulder JW, Coutinho RA, van der Noordaa J, Goudsmit J. Markers for progression to acquired immune deficiency syndrome and zidovudine treatment of asymptomatic patients. The Journal of Infection. 18: 85-91. PMID 2492586 DOI: 10.1016/S0163-4453(89)80087-8 |
0.744 |
|
| 1989 |
Mckeating JA, Gow J, Goudsmit J, Pearl LH, Mulder C, Weiss RA. Characterization of HIV-1 neutralization escape mutants. Aids. 3: 777-784. PMID 2483618 DOI: 10.1097/00002030-198912000-00001 |
0.448 |
|
| 1989 |
Goudsmit J, Kuiken CL, Nara PL. Linear versus conformational variation of V3 neutralization domains of HIV-1 during experimental and natural infection. Aids. 3. PMID 2482053 DOI: 10.1097/00002030-198901001-00017 |
0.421 |
|
| 1989 |
Wolfs TFW, Geelen JLMC, Schellekens H, Barin F, Dekker JT, Goudsmit J. Serum capacity to inhibit reverse transcriptase in vitro distinguishes HIV-1 infection from HIV-2 or SIV infection. Aids Research and Human Retroviruses. 5: 535-540. PMID 2480153 DOI: 10.1089/Aid.1989.5.535 |
0.512 |
|
| 1989 |
Goudsmit J, Zwart G, Bakker M, Smit L, Back N, Epstein L, Kuiken C, d'Amaro J, Wolf Fd. Antibody recognition of amino acid divergence within an HIV-1 neutralization epitope Research in Virology. 140: 419-436. PMID 2479966 DOI: 10.1016/S0923-2516(89)80120-7 |
0.431 |
|
| 1989 |
Goudsmit J, Bakker M, Smit L. Immunodominant B-cell clones responsive to an HIV-1 neutralization and cell fusion inhibition epitope in chimpanzee-to-chimpanzee passages of HTLV-IIIB and LAV-1 Research in Virology. 140: 405-418. PMID 2479965 DOI: 10.1016/S0923-2516(89)80119-0 |
0.386 |
|
| 1989 |
Meloen RH, Liskamp RM, Goudsmit J. Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity. The Journal of General Virology. 1505-12. PMID 2471813 DOI: 10.1099/0022-1317-70-6-1505 |
0.313 |
|
| 1989 |
Boucher CA, de Wolf F, Houweling JT, Bakker M, Dekker J, Roos MT, Coutinho RA, van der Noordaa J, Goudsmit J. Antibody response to a synthetic peptide covering a LAV-1/HTLV-IIIB neutralization epitope and disease progression. Aids (London, England). 3: 71-6. PMID 2469437 DOI: 10.1097/00002030-198902000-00003 |
0.712 |
|
| 1989 |
Goudsmit J, Bakker M, Smit L, Meloen RH. Specificity of chimpanzee antibodies binding a strain-specific HIV-1 neutralization epitope of the external envelope. Journal of Medical Primatology. 18: 357-362. DOI: 10.1111/J.1600-0684.1989.Tb00238.X |
0.424 |
|
| 1988 |
Lange JM, Goudsmit J, De Wolf F, Coutinho RA, van der Noordaa J. Serological markers in HIV infection. Annales De Mã©Decine Interne. 139: 80-3. PMID 3293504 |
0.738 |
|
| 1988 |
Epstein LG, Sharer LR, Goudsmit J. Neurological and neuropathological features of human immunodeficiency virus infection in children. Annals of Neurology. 23: S19-23. PMID 3279902 DOI: 10.1002/Ana.410230709 |
0.449 |
|
| 1988 |
Goudsmit J, Ljunggren K, Smit L, Jonda M, Fenyö E. Biological significance of the antibody response to HIV antigens expressed on the cell surface Archives of Virology. 103: 189-206. PMID 3265052 DOI: 10.1007/Bf01311092 |
0.447 |
|
| 1988 |
de Wolf F, Lange JM, Houweling JT, Coutinho RA, Schellekens PT, van der Noordaa J, Goudsmit J. Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. The Journal of Infectious Diseases. 158: 615-22. PMID 3261763 DOI: 10.1093/Infdis/158.3.615 |
0.7 |
|
| 1988 |
de Wolf F, Lange JM, Bakker M, Tjong-A-Hung S, Hooykaas C, Coutinho R, van der Noordaa J, Goudsmit J. Influenza-like syndrome in homosexual men: a prospective diagnostic study. The Journal of the Royal College of General Practitioners. 38: 443-5. PMID 3256668 |
0.744 |
|
| 1988 |
van Griensven GJ, de Vroome EM, Tielman RA, Goudsmit J, van der Noordaa J, de Wolf F, Coutinho RA. Impact of HIV antibody testing on changes in sexual behavior among homosexual men in The Netherlands. American Journal of Public Health. 78: 1575-7. PMID 3189635 DOI: 10.2105/Ajph.78.12.1575 |
0.643 |
|
| 1988 |
Geelen JL, Minnaar RP, Boom R, van der Noordaa J, Goudsmit J. Heat-shock induction of the human immunodeficiency virus long terminal repeat. The Journal of General Virology. 69: 2913-7. PMID 3183632 DOI: 10.1099/0022-1317-69-11-2913 |
0.636 |
|
| 1988 |
de Gans J, Portegies P, Derix MM, Troost D, Valk J, Goudsmit J. [The AIDS-dementia complex: primary infection by human immunodeficiency virus type I]. Nederlands Tijdschrift Voor Geneeskunde. 132: 1570-5. PMID 3173530 |
0.619 |
|
| 1988 |
Pronk JC, Frants RR, Crusius B, Eriksson AW, Wolf Fd, Boucher CAB, Bakker M, Goudsmit J. No predictive value of GC phenotypes for HIV infection and progression to AIDS Human Genetics. 80: 181-182. PMID 3169742 DOI: 10.1007/Bf00702864 |
0.472 |
|
| 1988 |
Goudsmit J, Thiriart C, Smit L, Bruck C, Gibbs CJ. Temporal development of cross-neutralization between HTLV-III B and HTLV-III RF in experimentally infected chimpanzees Vaccine. 6: 229-232. PMID 3166553 DOI: 10.1016/0264-410X(88)90216-2 |
0.348 |
|
| 1988 |
Thiriart C, Goudsmit J, Schellekens P, Barin F, Zagury D, Wilde MD, Bruck C. Antibodies to soluble CD4 in HIV-1-infected individuals. Aids. 2: 345-351. PMID 3146262 DOI: 10.1097/00002030-198810000-00003 |
0.503 |
|
| 1988 |
Van Den Hoek JAR, Coutinho RA, Van Haastrecht HJA, Van Zadelhoff AW, Goudsmit J. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam Aids. 2: 55-60. PMID 3128998 DOI: 10.1097/00002030-198802000-00010 |
0.376 |
|
| 1988 |
De Gans J, Lange JMA, Derix MMA, De Wolf F, Eeftinck Schattenkerk JKM, Danner SA, Ongerboer De Visser BW, Cload P, Goudsmit J. Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine Aids. 2: 37-40. PMID 3128994 DOI: 10.1097/00002030-198802000-00006 |
0.464 |
|
| 1988 |
Lange JMA, Parry JV, Wolf Fd, Mortimer PP, Goudsmit J. Diagnostic value of specific IgM antibodies in primary HIV infection Aids. 2: 31-36. PMID 3128993 DOI: 10.1097/00002030-198802000-00005 |
0.5 |
|
| 1988 |
Miedema F, Petit AJ, Terpstra FG, Schattenkerk JK, de Wolf F, Al BJ, Roos M, Lange JM, Danner SA, Goudsmit J. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. The Journal of Clinical Investigation. 82: 1908-14. PMID 2974045 DOI: 10.1172/Jci113809 |
0.483 |
|
| 1988 |
De Wolf F, Roos M, Lange JM, Houweling JT, Coutinho RA, van der Noordaa J, Schellekens PT, Goudsmit J. Decline in CD4+ cell numbers reflects increase in HIV-1 replication. Aids Research and Human Retroviruses. 4: 433-40. PMID 2905892 DOI: 10.1089/Aid.1988.4.433 |
0.749 |
|
| 1988 |
de Ronde A, Reiss P, Dekker J, de Wolf F, van den Hoek A, Wolfs T, Debouck C, Goudsmit J. Seroconversion to HIV-1 negative regulation factor. Lancet (London, England). 2: 574. PMID 2900962 DOI: 10.1016/S0140-6736(88)92703-1 |
0.429 |
|
| 1988 |
Reiss P, Lange JA, Boucher C, Danner S, Goudsmit J. Resumption Of Hiv Antigen Production During Continuous Zidovudine Treatment The Lancet. 331: 421. PMID 2893226 DOI: 10.1016/S0140-6736(88)91219-6 |
0.446 |
|
| 1988 |
de Wolf F, Lange JM, Goudsmit J, Cload P, de Gans J, Schellekens PT, Coutinho RA, Fiddian AP, van der Noordaa J. Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects. Lancet. 1: 373-6. PMID 2893187 DOI: 10.1016/S0140-6736(88)91179-8 |
0.729 |
|
| 1988 |
Goudsmit J. Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts. Aids. 2. PMID 2465771 DOI: 10.1097/00002030-198800001-00006 |
0.448 |
|
| 1988 |
Krone WJA, Debouck C, Epstein LG, Heutink P, Meloen R, Goudsmit J. Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo Journal of Medical Virology. 26: 261-270. PMID 2462614 DOI: 10.1002/Jmv.1890260306 |
0.51 |
|
| 1988 |
Goudsmit J, Debouck C, Meloen RH, Smit L, Bakker M, Asher DM, Wolff AV, Gibbs CJ, Gajdusek DC. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proceedings of the National Academy of Sciences of the United States of America. 85: 4478-82. PMID 2454471 DOI: 10.1073/Pnas.85.12.4478 |
0.464 |
|
| 1988 |
Schattenkerk JKME, Danner SA, Lange JMA, Paul DA, Van Boxtel CJ, Miedema F, Schellekens PTA, Goudsmit J. Persistence of Human Immunodeficiency Virus Antigenemia in Patients With the Acquired Immunodeficiency Syndrome Treated With a Reverse Transcriptase Inhibitor, Suramin: Ten-Patient Case-Control Study Archives of Internal Medicine. 148: 209-211. PMID 2447847 DOI: 10.1001/Archinte.1988.00380010211022 |
0.494 |
|
| 1988 |
Wolfs TF, Breederveld C, Krone WJ, Hoek Lvd, Bakker M, Smit L, Goudsmit J. HIV-antibody seroconversions in Dutch haemophiliacs using heat-treated and non heat-treated coagulation factor concentrates. Thrombosis and Haemostasis. 59: 396-399. DOI: 10.1055/S-0038-1647503 |
0.415 |
|
| 1987 |
Goudsmit J, Smit L, Klaver B, Asher DM, Wolff A, Gibbs CJ, Gajdusek DC. Induction in chimpanzees of antibodies inhibiting receptor-mediated cell fusion by HIV glycoprotein. Viral Immunology. 1: 225-40. PMID 3509947 DOI: 10.1089/Vim.1987.1.225 |
0.516 |
|
| 1987 |
van Griensven GJ, Tielman RA, Goudsmit J, van der Noordaa J, de Wolf F, de Vroome EM, Coutinho RA. Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands. American Journal of Epidemiology. 125: 1048-57. PMID 3495173 DOI: 10.1093/Oxfordjournals.Aje.A114620 |
0.668 |
|
| 1987 |
Goudsmit J, Smit L, Krone WJ, Bakker M, van der Noordaa J, Gibbs CJ, Epstein LG, Gajdusek DC. IgG response to human immunodeficiency virus in experimentally infected chimpanzees mimics the IgG response in humans. The Journal of Infectious Diseases. 155: 327-31. PMID 3492573 DOI: 10.1093/Infdis/155.2.327 |
0.631 |
|
| 1987 |
Goudsmit J, Lange JMA, Krone WJA, Teunissen MBM, Epstein LG, Danner SA, van den Berg H, Breederveld C, Smit L, Bakker M, de Wolf F, Coutinho RA, van der Noordaa J. Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapy Journal of Virological Methods. 17: 19-34. PMID 3478346 DOI: 10.1016/0166-0934(87)90065-6 |
0.719 |
|
| 1987 |
Goudsmit J, Epstein LG, Paul DA, van der Helm HJ, Dawson GJ, Asher DM, Yanagihara R, Wolff AV, Gibbs CJ, Gajdusek DC. Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees. Proceedings of the National Academy of Sciences of the United States of America. 84: 3876-80. PMID 3473487 DOI: 10.1073/Pnas.84.11.3876 |
0.531 |
|
| 1987 |
Epstein LG, Goudsmit J, Paul DA, Morrison SH, Connor EM, Oleske JM, Holland B. Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy Annals of Neurology. 21: 397-401. PMID 3472486 DOI: 10.1002/Ana.410210413 |
0.471 |
|
| 1987 |
Goudsmit J, Lange JMA, Paul DA, Dawson GJ. Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection. The Journal of Infectious Diseases. 155: 558-560. PMID 3468176 DOI: 10.1093/Infdis/155.3.558 |
0.439 |
|
| 1987 |
Goudsmit J, Paul DA. Circulation of HIV antigen in blood according to stage of infection, risk group, age and geographic origin. Epidemiology and Infection. 99: 701-710. PMID 3428375 DOI: 10.1017/S0950268800066565 |
0.493 |
|
| 1987 |
Huisman JG, Winkel IN, Lelie PN, Tersmette M, Goudsmit J, Miedema F. Detection of Early Anti‐p24 HIV Responses in EIA‐ and Immunoblot‐Negative Individuals Vox Sanguinis. 53: 31-36. PMID 3310400 DOI: 10.1111/J.1423-0410.1987.Tb04910.X |
0.467 |
|
| 1987 |
de Wolf F, Goudsmit J, Paul DA, Lange JM, Hooijkaas C, Schellekens P, Coutinho RA, van der Noordaa J. Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. British Medical Journal (Clinical Research Ed.). 295: 569-72. PMID 3117235 DOI: 10.1136/Bmj.295.6598.569 |
0.756 |
|
| 1987 |
Epstein L, Blumberg B, Crowley J, Samuel K, Goudsmit J, Cook S, Dowling P. Serum antibodies to HTLV-I in human demyelinating disease. Acta Neurologica Scandinavica. 75: 231-3. PMID 2884798 DOI: 10.1111/J.1600-0404.1987.Tb07925.X |
0.325 |
|
| 1987 |
Lange J, Goudsmit J. Decline of antibody reactivity to HIV core protein secondary to increased production of HIV antigen. The Lancet. 329: 448-448. PMID 2880240 DOI: 10.1016/S0140-6736(87)90148-6 |
0.612 |
|
| 1987 |
Coutinho RA, Goudsmit J, Paul DA, de Wolf F, Lange J, van der Noordaa J. The natural history of HIV infection in homosexual men Annales De L'Institut Pasteur Virology. 138: 67-74. DOI: 10.1016/S0769-2617(87)80076-X |
0.693 |
|
| 1987 |
Goudsmit J, de Wolf F, van de Wiel B, Smit L, Bakker M, Lent NA, Coutinho RA. Spread of human T-cell leukemia virus (HTLV-I) in the Dutch homosexual community Journal of Medical Virology. 23: 115-121. DOI: 10.1002/Jmv.1890230204 |
0.513 |
|
| 1986 |
van Griensven GJ, Tielman RA, Goudsmit J, van der Noordaa J, de Wolf F, Coutinho RA. [LAV/HTLV-III infection among a group of homosexual men; prevalence and psychosocial factors]. Nederlands Tijdschrift Voor Geneeskunde. 130: 2178-80. PMID 3492678 |
0.545 |
|
| 1986 |
Lange JM, Paul DA, Huisman HG, de Wolf F, van den Berg H, Coutinho RA, Danner SA, van der Noordaa J, Goudsmit J. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. British Medical Journal (Clinical Research Ed.). 293: 1459-62. PMID 3099912 DOI: 10.1136/Bmj.293.6560.1459 |
0.761 |
|
| 1986 |
Goudsmit J, Wolters EC, Bakker M, Smit L, Van der Noordaa J, Hische EA, Tutuarima JA, Van der Helm HJ. Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex. British Medical Journal (Clinical Research Ed.). 292: 1231-4. PMID 3011184 DOI: 10.1136/Bmj.292.6530.1231 |
0.644 |
|
| 1986 |
Melief CJM, Goudsmit J. Transmission of lymphotropic retroviruses (HTLV-I and LAV/HTLV-III) by blood transfusion and blood products Vox Sanguinis. 50: 1-11. PMID 3006350 DOI: 10.1111/J.1423-0410.1986.Tb04837.X |
0.34 |
|
| 1986 |
Coutinho RA, Krone WJ, Smit L, Albrecht-van Lent P, van der Noordaa J, Schaesberg W, Goudsmit J. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam. Genitourinary Medicine. 62: 38-43. PMID 3005159 DOI: 10.1136/Sti.62.1.38 |
0.651 |
|
| 1986 |
Lange JM, Coutinho RA, Krone WJ, Verdonck LF, Danner SA, van der Noordaa J, Goudsmit J. Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus. British Medical Journal (Clinical Research Ed.). 292: 228-30. PMID 3004634 DOI: 10.1136/Bmj.292.6515.228 |
0.698 |
|
| 1986 |
Reesink H, Huisman JG, Gonsalves M, Winkel IN, Hekker AC, Lelie PN, Schaasberg W, Aaij C, Does JAv, Desmyter J, Goudsmit J. Evaluation Of Six Enzyme Immunoassays For Antibody Against Human Immunodeficiency Virus The Lancet. 328: 483-486. PMID 2875239 DOI: 10.1016/S0140-6736(86)90358-2 |
0.42 |
|
| 1986 |
Goudsmit J, de Wolf F, Paul DA, Epstein LG, Lange JM, Krone WJ, Speelman H, Wolters EC, Van der Noordaa J, Oleske JM. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet. 2: 177-80. PMID 2873436 DOI: 10.1016/S0140-6736(86)92485-2 |
0.756 |
|
| 1986 |
Goudsmit J, Houwers DJ, Smit L, Nauta IM. LAV/HTLV-III gag gene product p24 shares antigenic determinants with equine infectious anemia virus but not with visna virus or caprine arthritis encephalitis virus Intervirology. 26: 169-173. PMID 2438251 DOI: 10.1159/000149697 |
0.354 |
|
| 1985 |
Goudsmit J, Miedema F, Wijngaarden-du Bois RJ, Roos MT, Schellekens PT, Coutinho RA, van der Noordaa J, Melief CJ. Immunoglobulin subclasses of antibodies to human T-cell leukemia/lymphoma virus I-associated antigens in acquired immune deficiency syndrome and lymphadenopathy syndrome. Journal of Virology. 53: 287-91. PMID 2981348 DOI: 10.1128/Jvi.53.1.287-291.1985 |
0.624 |
|
| 1983 |
Goudsmit J, van der Noordaa J. [Antiherpetics and their indications]. Nederlands Tijdschrift Voor Geneeskunde. 127: 597-602. PMID 6304541 |
0.508 |
|
| 1983 |
Goudsmit J, Tersmette T, Kabel P, Miedema F, Melief C. IgG antibodies to HTLV-III associated antigens in patients with AIDS and at risk for AIDS in the Netherlands Aids Research. 1: 231-236. PMID 6100824 DOI: 10.1089/Aid.1.1983.1.231 |
0.352 |
|
| 1983 |
Goudsmit J, Wertheim-van Dillen P, Schellekens PT, Coutinho RA, Danner SA, van der Noordaa J. Acquired immune deficiency syndrome, altered T cell subset ratios, and cytomegalovirus infections among male homosexuals in The Netherlands. Antibiotics and Chemotherapy. 32: 138-46. PMID 6087724 DOI: 10.1159/000409714 |
0.59 |
|
| 1982 |
Goudsmit J, Wertheim-van Dillen P, van Strien A, van der Noordaa J. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. Journal of Medical Virology. 10: 91-9. PMID 6292361 DOI: 10.1002/Jmv.1890100203 |
0.608 |
|
| 1981 |
Goudsmit J, van Crevel H, van der Noordaa J. [Creutzfeldt-Jakob disease: diagnosis, transmissibility and preventive measures in the examination and nursing care of patients]. Nederlands Tijdschrift Voor Geneeskunde. 125: 1411-3. PMID 7024828 |
0.675 |
|
| 1981 |
Goudsmit J, Baak ML, Sleterus KW, Van der Noordaa J. Human papovavirus isolated from urine of a child with acute tonsillitis. British Medical Journal (Clinical Research Ed.). 283: 1363-4. PMID 6274474 DOI: 10.1136/Bmj.283.6303.1363-A |
0.558 |
|
| Show low-probability matches. |
